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By creating antibodies against antigens, B-cells, also named B-lymphocytes, play 
an important role in the immune system to fight against foreign invasion to the host body. 
Within the antigen specific to a certain B-cell antibody, the sections recognized and 
bound by antibody are called B-cell epitopes. As antigenic determinants, B-cell epitope 
identification is of vital importance in many immunological processes, such as vaccine 
design, immunodiagnostic tests, and antibody production. Towards this goal, biologists 
and immunologists have applied a variety of methods to identify B-cell epitopes through 
both experiments and bioinformatic predictions. Since the experiments for searching B-
cell epitopes are time-consuming and expensive, bioinformatic methodologies have 
become important for the high-throughput study of B-cell epitopes. 
There are two kinds of B-cell epitopes: linear (continuous) epitopes and 
conformational (discontinuous) epitopes. The methodologies and difficulties of 
bioinformatic predictions for the two categories are quite different. Due to more 
challenges of conformational B-cell epitope prediction, currently most of prediction tools 
aim to linear B-cell epitope. 
  
 
The importance of B-cell epitopes has driven the development of faster and more 
precise tools in the past thirty years. Unfortunately, the limited success of these existing 
methods cannot match expectation because the achieved specificity and sensitivity leave 
room to be desired. In this dissertation, we developed new linear B-cell epitope tool 
SVMTriP with a sensitivity of 80.1% and a precision of 55.2%, which is higher than 
other tools such as BCPred and AAP (Chapter Two). We also developed new 
conformational B-cell prediction tool EPSVR and a meta server EPmeta based on 
Support Vector Regression (Chapter Three). Comparing to other conformational B-cell 
prediction tools such as DiscoTope, EPSVR shows a better prediction with AUC (Area 
Under receiver operating characteristic Curve) of 0.597. In addition, we are working on 
the tool SVMKER to predict epitopic residues on antigen (Chapter Four). To our 
knowledge, SVMKER is the first epitopic residue prediction tool just using protein 
sequence as input. These online tools will provide more choices for the identification of 
protein epitope by bioinformatic methodology.  
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CHAPTER ONE: THE IMMUNE SYSTEM AND B-CELL EPITOPES 
1. Introduction to the Immune System 
1.1 Immune system 
Our immune system protects us throughout our lives against surrounding 
pathogenic factors, such as viruses, bacteria, pathogenic fungi and eukaryotic parasites. 
This powerful and profound system can usually be divided into two major categories: the 
innate immune system and the adaptive immune system (1). The innate immune system, 
also called the non-specific immune system, is the first defense line to fight against the 
invaders. The basic components of the innate immune system include barrier epithelial 
cells, in vivo sentinel cells for recognition and following removal, and Natural Killer cells 
for killing invader. The innate system demonstrates a generic immune response to 
varieties of pathogens. Sentinel cells, for example, present so-called pattern recognition 
receptors (PRRs) on their surfaces. PRRs recognize pathogen-associated molecular 
patterns (PAMPs) presented exclusively on microbe pathogens. Since PAMPs are shared 
by different pathogenic sources, the inflammatory responses followed by the recognition 
of PAMPs by PRRs are still non-specific (1). Furthermore, the innate immune system 
cannot confer memorable and long-lasting immunity to the host.  
In contrast to the innate immune system, the adaptive system responds to 
pathogens in a completely different manner. During adaptive mechanisms, highly 
specialized white blood cells carry on adaptive immune responses to known or unknown 
pathogens on the second and third defense lines of the whole immune system. The 
adaptive immune system uses a small number of genes to express a large amount of 
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different antigen receptors. These receptors are uniquely expressed in different individual 
lymphocytes, and the offspring cells of lymphocytes inherit the same receptor specificity. 
As a consequence, the immunity acquired by the adaptive immune system can be learned, 
memorized, and then kept for long-lasting protection. Therefore, the adaptive immune 
system represents a more flexible evolutionary protection strategy against fugitive and 
unstable environment than the innate one (2). Among the entire defensive lines of the 
immune systems, T- and B-cells play the most important roles to recognize, lock, and 
eliminate the potentially harmful invaders. They will are discussed in the next section. 
1.2 T-Cell and B-cell 
Among immune components, T- and B-cells have been given the most attention 
by immunologists. Both T- and B-cells belong to one kind of white blood cells called 
lymphocytes, but the immune responses mediated by the two cell types are entirely 
different. T-cell immunity is based on cell-mediated attacks against foreign invaders into 
the host, while B-cell specifically plays an important role on so-called humoral immunity, 
which generates antibodies to search and recognize harmful antigens. Both T- and B-cells 
are initiated in bone marrow. However, T-cells are transferred to the thymus before their 
maturation, whereas B-cells stay in bone marrow until maturation. After mature T- or B-
cells form, they will both immigrate to the bloodstream and be transferred throughout the 
host body. 
According to their distinct roles, T-cells may be classified into multiple subgroups, 
including 1) Helper T-cells, 2) Cytotoxic T-cells, 3) Memory T-cells, and 4) Regulatory 
T-cells. Helper T-cells are also called CD4+ T-cells due to the expression of the protein 
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CD4 on the surface of mature helper T-cells. By secreting cytokines, helper T-cells 
function on the maturation of B-cells, activation of cytotoxic T-cells, and enhancement of 
the immune response of macrophages. Cytotoxic T-cells (also called CD8+ T-cells) can 
kill infected target T-cells directly, so sometimes they are also called T-killer cells. 
Cytotoxic T-cells may also kill tumor cells and even normal cells of a transplanted organ 
after surgery. Memory T-cells once experience the antigen-mediated infection, show a 
faster and stronger immune response when encountering the cognate antigen at the 
second time. The immunological memory comes from the proliferation and 
differentiation of naive T-cells undergoing the activation by antigen. 4) Regulatory T-
cells (also known as suppressor T-cells) are a subset of specific T-cells involved in 
immunological tolerance. Regulatory T-cells suppress immune responses of other T-cells 
that can cause tissue damage. They induce tolerance to self-antigens and avoid 
autoimmune diseases (3). Despite the different roles of these T-cells, their immune 
responses are mediated by the cells themselves. It means that these cells are directly 
involved in recognition, binding, and destroying of foreign invaders. 
Unlike the direct action of T-Cells, B-cells produce a variety of antibodies to 
obtain specific recognition to antigens. These antibodies, also called immunoglobulins, 
are a class of secreted proteins with a special Y shape. The Y shape of an antibody is 
composed of three components, one containing two C termini of heavy chains and the 
other two containing N termini of heavy chains and the whole light chains. Among a 
heavy chain, its C terminus is connect to N terminus by a flexible connecting chain 
(Figure 1.1). Therefore, the existence of these flexible connection chains can be adaptive 
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to the movement of N-terminus of Y shape, and enhance the binding of the light chains 
with antigens. 
 
Figure 1.1 The Y shape of an antibody (top) and the 3D structure of the antibody 
(down, PDB ID: 1IGT) (4). Commonly, an antibody is composed of two light and two 
heavy chains. The flexible chains in the middle of the heavy chains determine the 
conformation of the antigen binding site of the antibody. 
Although all the antibodies share the same Y shape, they can be categorized into 
five classes (IgA, IgD, IgE, IgG, and IgM) due to different C regions that are C terminus 
of heavy chain. Each class of antibody has its own in vivo location, acceptor, and specific 
biological function (1, 2). For example, IgA is the dominant antibody class in the 
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mucosal immune system such as the gut, respiratory tract and urogenital tract. IgA may 
prevent pathogen adherence. IgD may function to bind an antigen receptor when a B-cell 
meets with an unknown antigen. IgE is an especially interesting subclass of antibodies 
because it is mainly involved in allergic response. The interaction of allergen and IgE 
triggers the activation of mast T-cells, leading to a series of allergy-related characteristics. 
IgE is also found in autoimmune diseases. IgG is the major form in antibody-mediated 
immunity. It can search and recognize different antigens by taking different forms. In 
addition, IgG is the only antibody class that is transferred from mother to fetus through 
the placenta in passive immunity. IgM has a strong binding to pathogens. If there is no 
sufficient IgG, IgM may act instead to eliminate pathogens. Together, these five classes 
of antibodies can accomplish humoral immunity mediated by B-cells. 
Studies on antibodies advance vaccine invention. A given kind of antibody may 
uniquely bind to its corresponding antigen. At the same time, the immuno-property of the 
antibody can usually be inherited and memorized by the host body as discussed above. 
The injection of vaccine (which actually is a „dead‟ or inactive antigen) to the host body 
aims at the production of corresponding antibody by the in vivo immune system. The 
antibody may be memorized and kept effective against future invasions by the same 
active antigen for a period of time. Hence, understanding the interactions between 
antigens and antibodies becomes a key step to design novel vaccines against different 
kinds of diseases which patients are currently suffering with. 
2. Antibody-antigen complex 3D structure 
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The most accurate way to study the antibody-antigen interaction is with a 3D 
complex structure. Unfortunately, there is a very limited number of antibody-antigen 
complex 3D structures in Protein Data Bank (PDB, 
http://www.rcsb.org/pdb/home/home.do) (5). For example, for Homo sapiens, there are 
only approximately 200 antibody-antigen complex 3D structures available in the PDB as 
of May 20
th
, 2013. To put this in perspective, it has been estimated that humans generate 
10 billion different antibodies, therefore forming 10 billion unique interactions with their 
corresponding antigens (6). Among the 3D structures, most of them show a roughly 
similar appearance due to the special Y shape of the antibody. Using protein structure 
4JAN as example (Figure 1.2), we may clearly find that the antigen-binding site of the 
antibody is located at the component which contains the entire light chain and a part of 
heavy chain. The same binding pattern is also found in other antibodies. 
 Although it is a kind of protein-protein interaction, antibody-antigen binding 
seems quite distinctive from other protein-protein interactions due to the specific roles of 
antibodies. First of all, the antibody-antigen complex is categorized as non-obligate 
which means the individual antibody and antigen also exist in vivo accompanying the 
antibody-antigen complex. Furthermore, this kind of non-obligate antibody-antigen 
complex is proven to be transient, which means the affinity between the antibody and the 
antigen is also not strong (6). Therefore, considering their specific binding patterns, 
antibody-antigen interactions cannot be studied by simply applying regular protein-
protein interaction strategies, especially when trying to develop prediction tools for 
antibody-antigen interactions. 
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To investigate antibody-antigen complexes, much attention has been given to the 
antibody-binding site of antigens since this small portion of the antigen structure is in 
direct charge of binding with the antibody (13). For one thing, the identification of 
antibody-binding sites is a relatively easier task in structural biology due to their 
decreased sizes compared with the complete antigen proteins. Moreover, epitope 
identification is also the most vitally important part in antigen studies for medical 
applications, such as immuno-diagnosis and the development of novel vaccines. B-cell 
epitopes will be discussed in detail in the next section. 
 
Figure 1.2 Crystal structure of broadly neutralizing antibody CH103 in complex 
with HIV-1 gp120 (PDB ID: 4JAN) (8). An antibody binds to the antigen through its 
light-heavy overlap chain.  
 
3. B-cell Epitope 
3.1 Introduction to B-cell Epitopes 
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Epitopes are the antigenic determinants involved in antibody-antigen interactions. 
B-cells are commonly found in most mammals. By creating antibodies against antigens, 
B-cells play an important role in the immune system to fight against pathogenic invasions. 
Among the antigens related to B-cells, the sections recognized and bound by antibodies 
are called B-cell epitopes (Figure 1.3). Since they are antigenic determinants, the 
identification of B-cell epitopes helps biologists and immunologists investigate the 
pathways in the body‟s self-protection systems (9). 
 
 
Figure 1.3 Epitope is the antibody-binding site on an antigen. The blue region of the 
antigen which binds to the antibody is called an epitope. 
There are two types of B-cell epitopes. Linear (continuous) epitopes are short 
peptides containing a contiguous amino acid sequence, whereas conformational 
(discontinuous) epitopes are composed of amino acids that are not contiguous in 
sequence but close in the 3D structures (10).Some researchers have the view that the 
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boundary between linear and conformational epitopes is vague, because one 
conformational epitope may be seen as the combination of more than one shorter linear 
epitopes (13). The searching of conformational B-cell epitopes is much more difficult 
because the scarcely available 3D structure of an antigen is usually needed. Considering 
the complexity of conformational B-cell epitopes, most current research focuses instead 
on linear epitopes. The challenges of conformational B-cell epitope predictions will be 
discussed in detail in Chapter 3. 
3.2 Applications of B-cell Epitopes 
The identification of B-cell epitopes can be the foundation for many immuno-
applications. For example, with the knowledge of an epitope sequence, we can synthesize 
peptides mimicking the epitope for diagnosing human diseases, such as tuberculosis. 
Another more exciting application lies in vaccine design. A vaccine is the assumed „dead‟ 
or inactive form of a disease-caused pathogen, or any item can trigger immune response, 
hich is without the original activity or harmful impact on the host body. Vaccines can 
trigger the immune system and induce the production of correlated antibodies. For the 
host, the appearance of antibodies may be memorized and inherited so that the host body 
can be protected against the same „true‟ pathogen for a period, or even the whole lifetime. 
Vaccines are widely used for human beings from infancy to adulthood against many 
different pathogens and infections. For example, some epidemics which were once fatal 
to the world, such as smallpox, have been controlled efficiently due to the invention of 
disease-specific vaccines (11, 12). Hence, vaccine design is a medical application of vital 
importance, and many more novel vaccines against fatal diseases for public health are 
constantly under investigation and testing. 
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One key step for vaccine design is the determination of the epitope on an antigen.  
With this knowledge, by protein recombinant technologies, we may produce epitope-
based vaccines which reduces or eliminates the pathogenic sites of the real antigens. 
Hence, the epitope-based vaccines will keep the antigenicity and immunogenicity of the 
original antigens due to the presence of the epitopes, but lack the pathogenicity due to the 
absence of the active sites. When these epitope-based vaccines are injected into the host 
body to induce antibody genesis, they pose the least risk of adverse effects due to the 
minimal original antigen structures beyond the epitopes. At the same time, the immunity 
is triggered by epitope-based vaccines which then protects the host body against any 
future invasion of the same kind of antigen (13). Because of this unique advantage, the 
identification of B-cell epitopes is one of the major focuses of research for immunologists. 
4. Immunology and immunoinformatics 
4.1 Immunology 
Immunology focuses on the components, responses, and mechanisms of the 
immune systems of all organisms, especially humans and other vertebrates. Its origin may 
date back to the 18th century or even earlier. In 1796, Edward Jenner firstly discovered 
the induced protection against human smallpox disease by cowpox (14). The induction 
procedure was then called vaccination, which continues to be used today. After the first 
successful demonstration of vaccination, more and more practical vaccines, such as 
rabies vaccine (1885) (15) and influenza vaccine (1945) (16, 17), were found and 
approved for public use. In the serum of a vaccinated individual, Emil von Behring and 
Shibasaburo Kitasato (1898) for the first time found antibodies, the important substances 
specifically binding to corresponding pathogens, which initiated the era with the humoral 
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theory of immunity (18). Thereafter, the causes of infectious diseases were gradually 
discovered, and the roles of pathogenic sources, such as viruses, bacteria, fungi, and 
parasites, were determined as infectious agents. It was accepted that the immune system, 
as the in vivo self-protection mechanism, can automatically reduce or even eliminate the 
effect of invading pathogens. Due to the important medical relevance, the cells and body 
tissues involved in the immune system have been systematically studied since then. By 
understanding how the immune system works, immunologists may design clinical 
strategies to control the immune responses to both disease-causing pathogens and non-
harmful antigens. For example, antihistamine was designed to block histamine binding to 
histamine receptors and then inhibit the subsequent inflammatory responses. Hence, 
antihistamines may be used for allergy relief and to help patients reduce the pain from 
histamine-induced swelling and itching (3). Compared with most other biological 
branches, immunology is a rather new field with many immunological pathways and 
mechanisms still to be discovered. 
The study of immunology is not only challenging but also highly valuable. The 
level of complexity in the immune system comes from life itself. The evolution of life 
always finds a way so that the immune system keeps developing against the evolution of 
the pathogens and their ever-changing invasion strategies. As a consequence, there are 
always new topics to investigate when people attempt to uncover the details of the 
immune system. The immune system is so complex that immunology is divided into 
many individual sub-areas, such as classical immunology, clinical immunology, 
developmental immunology, diagnostic immunology, and evolutionary immunology. 
Varieties of immune organs or tissues, such as T-cell, B-cell, spleen, thymus, bone 
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marrow, and lymph, may be the unique research focuses for individual immunological 
research groups. The achievements from these immunological studies can provide 
valuable insights and strategies for medical applications. As an example, the influenza 
vaccine, a most common immunological application, has saved millions of lives since it 
was introduced to the public. In the history of influenza pandemic, influenza viruses, such 
as H1N1, H2N2, and H3N2, have taken away numerous human lives. For example, Some 
report estimated that spanish flu caused by H1N1 killed at least 50 million people in 
1918-1920 (19). Another H1N1 outbreak occurred in 2009 and ~185, 000 people died 
worldwide from April 2009 to August 2010. The lower mortality rate despite the more 
densely-populated world today was largely due to the invention and the widespread 
adoption of influenza vaccines (20). The induced antibody by the influenza vaccine may 
reduce the probability of virus infection and better protect us. As a consequence, due to 
their direct importance in medical applications, antibodies and their producer B cells are 
one major research focus for immunologists. 
4.2 Immunoinformatics 
The burgeoning immunological data drives a new field in immunology called 
immunoinformatics. Immunoinformatics is a branch of bioinformatics that has been 
developing quickly in the past decade. Using the principles of bioinformatics and 
computational biology, immunoinformatics researchers have begun to manage the 
collection, summary, data mining, and convenient Internet sharing of immunological 
resources. In addition to creating immune-related databases, a series of novel tools, such 
as data analysis, sequence alignments, and biophysical predictions, have been developed 
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to solve the questions on immunology. Below I summarize the development of 
immunoinformatics databases and prediction tools for B-cell epitopes. 
4.2.1 B-cell Epitope Databases 
  With the growing resources of B-cell epitopes, it is necessary to collect and 
organize known information on reported B-cell epitopes with well-designed structures 
into databases. At present, there are several databases available online and free for public 
access. Some of these databases focus on linear B-cell epitopes, such as Bcipep 
(http://www.imtech.res.in/raghava/bcipep/data. html) which contains 2479 known linear 
B-cell epitopes (21). Another popular B-cell epitope database is Immune Epitope 
Database (IEDB, http://www.iedb. org/) which collects not only linear B-cell epitopes but 
also conformational B-cell epitopes and 3D structures of antibody-antigen structures (22).  
Actually, IEDB collects much more entries than other B-cell epitope databases. For 
example, as of May 30, 2013, there are 63452 B-cell linear epitope entries, 2056 
conformational B-cell epitopes entries, and 646 3D structures of antibody-antigen 
complexes related to B-cell available in the IEDB database.  
The B-cell epitopes collected in the databases above still represent only a small 
portion of all antigenic determinants which the immunologists are interested in. There is a 
need to search and identify more. There are many ways to determine B-cell epitopes, 
including experimental searching strategies and bioinformatic prediction tools based on 
biostatistical and bioinformatic technologies. Experimental results are reliable but 
conducting such experiments is time- and resource- consuming. Sometimes such 
experimental searches could be blind or random, in the hope of identifying something 
useful. On the other hand, bioinformatic predictions have the alternative advantages, such 
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as fast speed and low cost, comparing to the experiments. Although such predictions 
suffer from intrinsic false-positive rates, the quick and high-throughput properties are 
highly desirable, allowing researchers to develop novel methods with improved 
prediction performance. Even though 100% accuracy cannot be achieved, the predicted 
epitopes from bioinformatic methods can greatly narrow down the searching space for 
subsequent experiments and validations, and provide reasonable candidates to decrease 
the randomness of experimental searches. Therefore, the development of bioinformatic 
prediction tools has been a vital part of the study on B-cell epitopes. Linear and 
conformational predictions will be reviewed in more detail in the following two sections. 
4.2.2 Principles of Linear B-cell Epitope Prediction 
The prediction of linear B-cell epitopes is easier than that of conformational 
epitopes. Usually, the linear B-cell epitope prediction tool is at the protein-sequence level. 
That is, many previous studies on linear B-cell epitope prediction are based on the 
physicochemical property (or propensity scale) of constituent amino acids. With the input 
of protein sequences, the prediction tools are based upon the amino acid properties 
including hydrophilicity (23, 24), solvent accessibility (25), secondary structure (26), 
flexibility , and antigenicity (27). These known B-cell linear epitope prediction tools 
include but are not limited to: PEOPLE (28), BEPITOPE (29), BepiPred (30), ABCPred 
(31), AAP (32), BCPred (33), BayesB (34), BEOracle/BROracle (35), and BEST (36). In 
these various prediction tools, different properties of amino acid sequences were applied. 
For example, PEOPLE utilized four kinds of physicochemical properties: secondary 
structure, hydrophilicity, surface accessibility, and flexibility (28). BEPITOPE declared 
more than 30 propensity scales such as hydrophobicity scales and flexibility (29). 
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BepiPred did a similar analysis using a number of propensity scales but using a different 
training dataset  (30). ABCPred specifically used a neural network to decrease the false 
positive rate in predicted linear B-cell epitopes (31). In more recent methods, string 
kernals such as spectrum, mismatch,  local alignment, and subsequence were applied in 
BCPred (33) while amino acid pair propensity was used in AAP (32). 
BEOracle/BROracle was based on features from evolutionary, structural and 
compositional information of antigen sequences (35). In BEST, optimal models were 
trained by combining information from the epitope sequence, sequence conservation, 
secondary structure, and relative solvent accessibility (36).  
Although different feature combinations based on antigen sequences were 
attempted by individual linear B-cell epitope prediction models, it is not yet known which 
combination provides optimal prediction performance. Furthermore, it seems that the 
“optimal” feature set may be biased by the training dataset chosen by individual research 
groups. For example, although BCPred tool received a higher AUC (Area Under receiver 
operating characteristic Curve) value than AAP using the Bcipep database, the two tools 
demonstrated approximately equal prediction performance when the IEDB database was 
used (44).  
Another differentiating factor about linear B-cell epitope prediction is the 
application of different machine learning platforms. The most common platforms are 
Support Vector Machine (SVM) (32, 33), Hidden Markov Model (HMM) (30), and 
Artificial Neural Network (ANN) (31). Support Vector Machine is one of the most 
popular supervised learning models used for classification, pattern recognition, and 
regression. A typical SVM is the binary linear classifier. With the input of two classes of 
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classified data, SVM defines the hyper plane as the boundary of two classes by 
calculating the maximum margin. The determination of the hyper plane is the main 
purpose of SVM algorithms. Derived changes, such as kernel trick in non-linear 
classification, may have effect on the hyper plane and be used to modify binary linear 
SVM. SVM has been widely applied, especially in the past decade, in the development of 
linear B-cell epitope prediction tools such as AAP (32), BCPred (33), BayesB (34), 
BEOracle/BROracle (35), and BEST (36). Other tools, such as BepiPred (30), applied 
HMM as their platform. HMM algorithms come from the field of statistics. Generally, 
HMM is deemed as a Markov model inside which there exists a Markov process 
containing unobserved middle states. The optimal model determination is similar to 
maximum likelihood estimation of the parameters involved in HMM given the training 
sequences. ANN is an information-processing paradigm involved in multiple lines of 
interconnected nodes (neurons) computing values from inputs, which has been applied in 
the reported linear B-cell epitope tool ABCPred (31). In contrast with SVM and HMM, 
ANN algorithms are much more complicated and require more calculation machine time.  
4.2.3 Linear B-cell Epitope Prediction Tools 
Below we will introduce and compare some popular linear B-cell epitope 
prediction tools. PEOPLE (Predictive Estimation Of Protein Linear Epitopes) was 
released in 1999 (28). It is a rather sample linear B-cell prediction tool. In PEOPLE, four 
kinds of basic properties of epitopes are used: secondary structure (mainly β-turns), 
surface accessibility, hydrophilicity, and flexibility. The four kinds of profiles are 
combined to calculate an antigenic index (AG). The AG is the final indicator to 
determine whether unknown small protein segments are epitopes. Although it is a rather 
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simple method, the four properties of epitopes used in PEOPLE are still popular in newly 
developed methods for the prediction of linear B-cell epitopes. 
BEPITOPE is an updated version of the PREDITOP program developed by 
Michael Odorico and Jean-Luc Pellequer in 2003 (29). It is not an online tool and needs 
to be installed on local machines. In the BEPITOPE program the authors evaluated more 
than 30 propensity scales, such as hydrophobicity (where the negative values indicate 
hydrophilic regions, and positive scales stand for flexible regions), to search for potential 
epitopes. These propensity scales were calculated by the comparison of real linear B-cell 
epitopes and non-epitopes. Hence, for the BEPITOPE program, the collection of epitope 
set and non-epitope set and the following calculation of propensity scale is of vital 
importance for prediction performance. Although the limited database of linear B-cell 
epitopes may limit the success of BEPITOPE, the propensity scales used in BEPITOPE 
have proven useful in more recently developed tools. 
BepiPred, released in 2006, applied a new strategy to predict linear B-cell 
epitopes (30). In BepiPred, the method relied on HMM. Like BEPTIOPE, propensity 
scales are the major indicator of epitope properties. The involvement of HMM improved 
prediction performance compared with naïve methods like PEOPLE. On its website 
(http://www.cbs.dtu.dk/services/BepiPred), the datasets used in BepiPred are also 
available. The sharing of datasets can be a good reference for other research groups when 
developing and benchmarking their methods, and promotes communication among the 
different research groups. 
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Like BepiPred, ABCPred also applied an interesting machine learning platform 
(31). Recurrent Neural Network is a powerful tool in the field of machine learning and it 
was used for the first time in linear B-cell epitope prediction by ABCPred. The dataset 
used by ABCPred is from Bcipep (21) after careful filtering of similar epitope sequences. 
The process of dataset construction in ABCPred was adopted by many later tools such as 
BCPred and AAP. In ABCPred, flexible epitope length was carefully discussed, and the 
suggested epitope size was no more than 20 amino acids (AA). To our knowledge, 
however, the optimal length of a certain linear B-cell epitope for prediction keeps 
unknown. 
AAP and BCPred are very popular linear B-cell epitope prediction tools (32, 33). 
Both tools are based on the SVM platform and filtered the training dataset from Bcipep 
database using a similar filtering process as in ABCPred. BCPred considered string 
patterns of epitope sequence while AAP applied amino acid pair antigenicity scale in the 
model. In addition, they both investigated and compared different window sizes of 
epitopes, such as 10, 12… and 20. AAP was released in 2007 and BCPred in 2008, and 
both are available online. 
BayesB added new ideas from statistics (34). Bayes feature extraction is a popular 
feature in statistical methods, and it was applied in the BayesB tool in 2010 to enhance 
the performance beyond SVM-based methods. The two datasets in BayesB were 
borrowed from that of AAP and BCPred, again demonstrating the advantage of online 
tools and dataset-sharing. The basic scales in BayesB are relevant position-specific amino 
acid propensities, similar to those used in BEPITOPE.  
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The BEOracle/BROracle (35) tool uses classic strategies for linear B-cell epitopes, 
such as composition of protein sequence properties (including secondary structure, 
solvent accessibility and evolutionary conservation), the popular platform SVM, and 
cross-validation process. Despite this classical approach, it succeeded in generating a 
large training dataset due to the availability of the IEDB database (22). The size of a 
dataset is of vital importance for the success of the prediction tool. Hence, the IEBD 
database gradually replaced Bcipep and became a basic resource for linear B-cell epitope 
prediction. 
BEST tool was released in 2013 (36). It considers evolutionary profiles generated 
by PSI-BLAST. The amino acid pair propensity scale developed for AAP and other 
protein sequence properties such as secondary structure and solvent accessibility were put 
into consideration by BEST. The increasing number of entries in the IEDB database 
offered a bigger training dataset, which benefited prediction performance. The success of 
the BEST tool demonstrated the utility of combining different traditional tools with a new 
and bigger training dataset. 
4.2.4 Principles of Conformational B-cell Epitope Prediction 
Conformational B-cell epitope prediction is more challenging than the task of 
linear prediction. Similar to linear B-cell epitope prediction tools, physicochemical 
properties of amino acid sequence are the major features used in the modeling algorithms. 
However, the difference between linear and conformational B-cell epitope predictions is 
the collection of training datasets. During the construction of datasets for known 
conformational B-cell epitopes, 3D structural information is usually required, which 
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presents a huge barrier for conformational B-cell epitope prediction. With more 3D 
structures of antigens, the latest conformational B-cell epitope prediction tools generally 
outperform their predecessors. 
At present, there are a limited number of available conformational B-cell epitope 
prediction tools, such as DiscoTope (37), BEpro (PEPITO) (38), ElliPro (39), SEPPA 
(41), EPITOPIA (42, 43), and Bpredictor (45). Different tools used different 
combinations of features, which may be biased by their own training datasets. For 
example, DiscoTope integrated a linear combination of two scores, the hydrophilicity 
scale and the epitope log-odds ratio, the latter of which is one kind of epitopic residue 
propensity scores (37). BEpro (PEPITO) also applied linear combination to two scores: 
the epitopic residue propensity and the half sphere exposure values at multiple distances 
(38). ElliPro used only one score, the residue protrusion index (PI) (39). SEPPA 
employed the epitopic residue propensity and the compactness of neighboring residues 
around one residue (e.g., contact number which is the number of Cα atoms in the antigen 
within a distance of 10Å of the Cα atom of target residue), again using linear 
combination (41). EPITOPIA applied a naive Bayesian classifier to forty-four 
physicochemical and structural–geometrical attributes, including secondary structure, 
epitopic residue propensity, evolutionary conservation score, solvent accessibility to the 
surface, and hydrophilicity etc  (42, 43). Bpredictor employed the Random Forest (RF) 
classifier to adjacent residue distance score, accessible surface area, conservation, 
secondary structure, and propensity etc (45).   
In general, the features used by these predictors include conservation score, 
structural features such as secondary composition, geometry characteristics such as 
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protrusion index and planarity score, and amino acid features such as hydrophilicity and 
propensity (odd-ratio). These attributes can be integrated by linear combination or 
machine-learning algorithms, such as naive Bayesian classifiers, Support Vector 
Regression (SVR), and RF classifiers. Different numbers of features were used in a given 
predictor, from two scores to forty-four attributes. For small numbers of attributes, a 
simple linear combination can usually work well, whereas large numbers of features 
often require sophisticated machine-learning algorithms to optimally integrate the scores. 
Notably, some of these features may be mutually exclusive or overlapping. For example, 
the antigenic epitope is frequently located at either a protruding region or a flat surface. 
In such cases, linearly combining the two incompatible terms contradicts the physical 
situation and will degrade the performance of a predictor. In the next section, we will 
introduce these feature applications in several conformational B-cell epitope prediction 
tools released in the past decade. 
4.2.5 Conformational B-cell Epitope Prediction Tools 
Below the popular conformational B-cell epitope prediction tools are introduced 
following the order of release dates, 
DiscoTope is the first conformational B-cell epitope prediction tool based on 
protein 3D structural information (37). DiscoTope uses linear combination to integrate 
two scores, the hydrophilicity scale and the epitope log-odds ratio, the latter of which is 
one kind of epitopic residue propensity scores (37). Its dataset was a group of 76 X-ray 
structures of antibody/antigen protein complexes. Compared with previous sequence-
level tools, the involvement of protein 3D structures offered a more reliable prediction to 
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guide experimental epitope mapping. From the training dataset, a log-odds-ratio was 
calculated and then applied in the construction of the DiscoTope model. On the other 
hand, the tool used simple linear combination rather than popular machine learning 
technologies, such as SVM or HMM. Nevertheless, since the release of DiscoTope in 
2006, the prediction of conformational B-cell epitopes shifted the focus to utilizing 
protein 3D structural data. 
PEPITO, released in 2008, tried to improve prediction performance by applying 
more features of the 3D structure of antibody/antigen protein complexes, such as multiple 
distance thresholds and sphere exposure (38). The dataset of DiscoTope was used by 
PEPITO due to the limited availability of antibody/antigen protein complexes in the PDB 
database. Amino acid propensity scales, which are usually used in sequence-based linear 
B-cell epitope prediction, were also incorporated by PEPITO to enhance predictive 
performance. 
ElliPro can accept either antigen 3D sequence and structure as input (39). If only 
a protein sequence is provided as input, ElliPro will firstly search protein structures in 
PDB based on sequence similarity and use the best-matched 3D structure as the input. 
ElliPro implemented Thornton‟s method which considers the shape of a protein as an 
approximate ellipsoid (40). ElliPro calculates the residue protrusion index (PI) and then 
clusters neighboring residues according to their PI values.  
SEPPA introduced a concept of „unit patch of residue triangle‟ to describe the 
local spatial context on the surface of a protein in 2009 (41). The unit patches were 
involved in the calculation of propensity indices and the following antigenicity scores. In 
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addition, the method constructed its own training dataset containing 84 structures. The 
test set with 119 antigens was from the training set of DiscoTope, IEDB, and Epitome. 
Machine learning platforms were not used in SEPPA. 
Different from the three tools above, EPITOPIA initiated the application of 
machine learning technologies for the prediction of conformational B-cell epitopes (42, 
43). It applied a Naive Bayes classifier to the construction of an online tool. A searching 
antigen input was firstly divided into overlapping surface patches. For each middle 
residue of a patch, its immunogenicity score was calculated by combining 
physicochemical and structural properties of the patch. For EPITOPIA, the 3D structure 
of the antigen is still a must for online prediction. 
We released the two conformational B-cell epitopes EPSVR 
(http://sysbio.unl.edu/EPSVR)  and a meta server EPmeta (http://sysbio.unl.edu/EPmeta)  
in 2010 (44). EPSVR applied the six physicochemical attributes to its surface patch. The 
six attributes include epitope propensity, conservation score, side chain energy score, 
contact number, surface planarity score, and secondary structure. More details will be 
introduced in chapter three. 
Bpredictor is a newer conformational B-cell epitope prediction tool released in 
2011 (45). For this tool, a new concept of „thick surface patch‟ was introduced to 
describe the local spatial context on a protein surface instead of „surface patch‟. It also 
compared the influences of different machine learning platforms. For example, SVM and 
ANN were found to be slower and more sensitive on parameter settings than RF. As to 
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dataset, Bpredictor borrowed the dataset from EPITOBIA and EPSVR (44). The latter is 
the conformational B-cell epitope prediction tool we released in 2009. 
5. Summary 
The importance of B-cell epitope drives us to develop new computational 
methods to predict epitopes on protein candidates. Currently the prediction of B-cell 
epitopes, including linear and conformational, still has a place to improve. In this 
dissertation, from chapter two to chapter four, we will introduce our newly developed 
methods to predict linear B-cell epitope (chapter two), conformational B-cell epitope 
(chapter three), and epitopic residues on antigen (chapter four) respectively. 
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CHAPTER TWO: PREDICTION OF LINEAR B-CELL EPITOPES 
1. Introduction 
By secreting antibodies against antigens, B-cells play an important role in the 
immune system to fight invading pathogenic organisms or substances. An antibody can 
specifically recognize and bind to an antigen, analogous to a key into a lock. Antigenic 
epitopes are regions of the antigen surface that are preferentially recognized by B-cell 
antibodies (1). Prediction of antigenic epitopes is useful for the investigation on the 
mechanism of body‟s self-protection systems and can help the design of vaccine 
components and immuno-diagnostic reagents (2). 
B-cell antigenic epitopes are classified as either continuous or discontinuous (3). 
A continuous (also called linear) epitope is a consecutive fragment from the protein 
sequence; a discontinuous epitope is composed of several fragments scattered along the 
protein sequence, but still form an antigen-binding interface in three dimensions. A 
distinction between continuous and discontinuous epitopes is vague; a continuous 
fragment in a discontinuous epitope can be considered as a linear epitope. The majority 
of currently available epitope prediction methods focus on continuous epitopes due to the 
relative simplicity of the problem, in which the amino acid sequence of a protein is taken 
as an input. These prediction methods are based upon the amino acid properties including 
hydrophilicity (4, 5), solvent accessibility (6), secondary structure (7), flexibility (8), and 
antigenicity (9). In addition, based on the epitope databases such as IEDB (10), Bcipep 
(11), and FIMM (12), some methods use machine learning approaches, such as hidden 
Markov models (HMM) (13), artificial neural networks (ANN) (14), and support vector 
machines (SVM) (15, 16), to locate linear epitopes. Such methods include: PREDITOP 
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(9), PEOPLE (17), BEPITOPE (18), BepiPred (13), ABCPred (14), AAP (15), BCPred 
(16), BayesB (19), BEOracle/ BROracle (20), and BEST (21).  
Currently available linear B-cell prediction tools show only a limited success. For 
example, one of the best available methods by 2011, BCPred, was reported as the 
accuracy and specificity of ~72% and ~79% using the five-fold cross-validation based on 
a dataset of 872 B-cell epitopes and 872 non-B-cell epitopes (16).To pursue more reliable 
and stable linear B-cell epitope prediction, immunoinformaticists need to develop new 
statistical models. The new models shall have lower false positive rates so that the 
prediction results can be more reliably used for experimental design.  
Since more information including experimentally determined linear B-cell 
epitopes and 3D structures of antigens has been released in the past decades, development 
of new linear epitope prediction methods became more feasible. For instance, the IEDB 
database collects much more known epitopes than before. With the advance in 
bioinformatics technology, new algorithms have been developed for the prediction of 
active sites of proteins. These innovations stimulate the development of the prediction 
tools of linear B-cell epitopes. 
In this chapter, we developed a new linear B-cell epitope prediction tool, 
SVMTriP, which uses a machine learning technique, SVM, with the tri-peptide similarity 
and propensity scores. SVMTriP was tested for varied epitope sequence lengths. With the 
five-fold cross-validation, SVMTriP achieves a sensitivity of 80.1% and a precision of 
55.2% for sequences with 20 amino acids (AA), which are higher than those of AAP 
(sensitivity:  59.8%, precision: 58.5%) and BCPred (sensitivity: 54.0%, precision: 60.5%).  
2. Materials and Methods 
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2.1 Datasets 
The dataset was constructed by extracting non-redundant linear B-cell epitopes 
from IEDB (10), which is frequently updated and has the most complete set of linear 
epitopes. Total of 65,456 redundant B-cell linear epitopes were obtained from IEDB 
(version June 11th, 2012). The identical epitopes and those possibly related to T-cell 
were removed. The full-length sequences of corresponding epitopes were also collected. 
Then, the various lengths of epitope sequences, including 10AA, 12AA, 14AA, 16AA, 
18AA, and 20AA, were extracted by trimming the long experimental measured epitopes 
or attaching more amino acid residues to both ends of short epitopes according to the full-
length sequences. For a given length, 65,456 epitope sequences are filtered by a threshold 
of less than30% similarity, measured by BLASTP (22), were clustered together and only 
one of them was kept as a representative epitope sequence in the dataset. Finally, the 
positive dataset for each length had a total of 4925 non-redundant epitope sequences. For 
the negative dataset, the same number of non-redundant sub-sequences with each equal 
length is extracted from the non-epitopic segments in the corresponding antigen 
sequences. 
2.2 Attributes 
2.2.1 Tri-peptide Scores Matrix 
The idea of tri-peptide score matrix was borrowed from the prediction method 
used in protein subcellular localization by Lei and Dai (23). A matrix D
k
 of high scored k-
peptide pairs is of dimension 20
k
 × 20
k
 (we did not consider X residue in BLOSUM or 
PAM matrix). The tri-peptide score matrix is defined as: 
T
(i)
= ∑(i)  j ,                                                    (1) 
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where (i) denotes the tri-peptide that represents the i-th attribute, j denotes the j-th tri-
peptide in the tri-peptide subsequence space for the input sequence. The symbol “” 
denotes getting the similarity score of any two corresponding tri-peptide, i.e., sum of 
three similarity scores for three amino acid pairs from a BLOSUM/PAM matrix. For 
example, assuming the length of a given epitope candidate is 20 AA, the tri-peptide 
subsequence similarity kernel for the i-th attribute is generated by summing over 
similarity scores of the 18 pairs of tri-peptide; each pair consists of one tri-peptide from 
the input sequence and the tri-peptide represents i-th attribute from the tri-peptide 
subsequence space. Using BLOSUM62 as example, the steps are shown below: 
a) A sliding window of 3AA along the sequence is used. 
b) The score T(i) is defined as the sum of the score for the respective individual 
residue pair from BLOSUM62 between two pairs of tri-peptide. The score T
(i)
 is 
zero if the sum of BLOSUM62 scores of three individual residue pairs is negative.  
c) Each value in 203 features is calculated from the average score T(i)s between the 
i
th
 tri-peptide and all of tri-peptides from step a. 
A graphic interpretation is shown in Figure 2.1 
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Figure 2.1 Illustration of tri-peptide score matrix construction. Each feature score is 
the average score of between the i
th
 tri-peptide and all the peptides from slide window of 
protein sequence. 
 
To build the tri-peptide score matrix, BLOSUM and PAM matrices, the most 
popular score matrices used for protein sequence alignment, were tested. BLOSUM 
matrices are derived from residue-residue substitution probability (24) while PAM is 
based on observed mutations of closely related proteins (25). In our study, different 
BLOSUM matrices were tested, such as BLOSUM30, BLOSUM50, BLOSUM62, and 
BLOSUM75, where the number represents the percentage identity threshold that are used 
for determining closely related protein groups during the construction of BLOSUM 
matrices. Different PAM matrices were used as well, such as PAM120, PAM160, 
PAM200, and PAM250, where the number stands for the times of multiplication of the 
primary PAM matrix (PAM1) by itself when building a PAM matrix. The application of 
different BLOSUM or PAM matrices would influence the prediction result of final 
models. 
2.2.2 Tri-peptide Subsequence Propensity 
The propensity of tri-peptide subsequence representing the i-th attribute is 
calculated as in Equation (2): 
,                                                     (2) 
where f
(i)
 is the frequency of i-th type of tri-peptide in the positive epitopes, and F
(i)
 is the 
background frequency of i-th type of tri-peptide in 5×10
4
 protein sequences randomly 
selected from the Refseq database (26). 
  
P (i) =
f (i )
F
(i )
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2.2.3 Integrations of Tri-peptide Scores Matrix and Tri-peptide Subsequence 
Propensity 
The tri-peptide subsequence space is used to encode the SVM attributes. This 
kernel has a space of 20
3 
attributes for both tri-peptide substring and propensity. The 
score of i-th attribute, K
(i)
, is defined as the tri-peptide subsequence similarity kernel 
modulated by its corresponding tri-peptide propensity. Please see Equation (3): 
K
(i) 
=T
(i)
 •P
(i)
,                                                             (3) 
where K
(i)
 denotes the score of the i-th attribute, T
(i)
 denotes the i-th tri-peptide score 
matrix calculated by Equation (1), and P
(i)
 denotes corresponding tri-peptide subsequence 
propensity of i-th tri-peptide subsequence calculated by Equation (2). Other features of 
physicochemical properties of amino acids, such as hydrophilicity and predicted 
secondary structure, had been also used to modify K
(i)
. For hydrophilic and hydrophobic 
residue group, two fixed weights, e.g., 0.5 and 2, will be used to change K
(i)
. 
2.2.3 Hydrophobicity 
Hydrophobicity scale of residue usually is applied to linear B-cell epitope 
prediction (17, 18). The hydrophobicity profile implies a hydrophobic region that tends to 
be located away from the surface of antigen protein.  A potential hydrophobic region 
represents a low probability to be an antibody-bind site.  Hence, hydrophobicity scale 
was used here in order to evaluate the probability of a residue locating on protein surface. 
Table 2.1 Hydrophobicity Scale Table 
Ala 1.8 Glu -3.5 Leu 3.8 Ser -0.8 
Arg -4.5 Gln -3.5 Lys -3.9 Thr -0.7 
Asn -3.5 Gly -0.4 Met 1.9 Trp -0.9 
Asp -3.5 His -3.2 Phe 2.8 Tyr -1.3 
Cys 2.5 Ile 4.5 Pro -1.6 Val 4.2 
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Amino acid hydrophobicity scales may be calculated by experimental biophysical 
methods. In our study, we used the hydrophobicity scale calculated by Jack Kyte shown 
in Table 2.1 (27). 
2.2.4 Secondary structure 
 The structural information directly declares the spatial location where the residues 
stay. 3D structure is of the most interest but it is also challenging to predict. There are, 
however, many mature secondary structure prediction methods available and the results 
from those tools usually are more reliable. Hence, many linear B-cell epitope prediction 
tools incorporate secondary structural data to their models (17, 20). We also considered 
secondary structure information. 
 To obtain the secondary structural information of antigen, we applied one of the 
popular protein secondary structure prediction tools, PSIPRED, which is based on 
position-specific scoring matrices (PSSM) from PSI-BLAST. In order to run a PSIPRED 
tool on a local machine, the BLAST tool and the associated NR database must also be 
downloaded and installed correctly. PSIPRED tool package is available on 
http://bioinfadmin.cs.ucl.uk/downloads/psipred/ (28) and BLAST can be downloadable 
from National Center for Biotechnology Information (NCBI) website 
(ftp://ftp.ncbi.nlm.nih.gov/blast/ executables/blast+/LATEST/) (22). 
2.3 Support Vector Machine Platform 
Support Vector Machine (SVM) was selected as the machine learning technique 
for our new models. SVM has been proven powerful in various biological and 
immunological applications, such as epitope prediction (15, 16), disease diagnostic (29, 
30), clinical outcome (31), and hub protein determination (32). SVM usually is associated 
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with learning algorithms for the application of classification and regression analysis. For 
example, a typical application is to generate binary linear classifier. SVM takes a set of 
two classes of objects as an input. By fitting the maximum-margin hyperplane, SVM 
determines the boundary between the two classes in a hyper-dimensional space. SVM 
then classifies an unknown object by checking where the unknown object is located 
besides the hyperplane in the hyper-dimensional space. Since developed by Vladimir N. 
Vapnik in 1963 (33), the theory of SVM has been differentiated into multiple branches, 
including linear model and nonlinear model, binary class SVM and multiclass SVM, and 
classic supervised learning SVM and semi-supervised transductive SVM. Many different 
SVM tools have been developed as listed in Table 2.2. Here we used SVM
light
 as a 
platform to train the optimal model. SVM
light
 is an easy standalone tool with customizable 
parameter options. It has been successfully applied in many SVM-based biological 
predictions, such as protein fold recognition. 
 
Table 2.2 Some Available Support Vector Machine Tools 
SVM Tool Downloadable Access 
SVM
light 
(34) http://svmlight.joachims.org/ 
SVM
struct 
(35) http://svmlight.joachims.org/svm_struct.html 
mySVM (36) http://www-ai.cs.uni-dortmund.de/SOFTWARE/MYSVM/index.html 
TinySVM http://chasen.org/~taku/software/TinySVM/ 
LIBSVM (37) http://www.csie.ntu.edu.tw/~cjlin/libsvm/ 
SVMTorch (38) http://bengio.abracadoudou.com/SVMTorch.html 
LS-SVMlab (39) http://www.esat.kuleuven.be/sista/lssvmlab/ 
 
2.4 Model Training and Evaluation 
2.4.1 Training Procedure 
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The SVM
light
 platform applies a series of parameters to obtain the optimal training 
models. Some important parameters include kernel type, c (trade-off between training 
error and margin), g (parameter γ of the radial basis function kernel), and p (fraction of 
unlabeled examples to be classified into the positive class). In our training procedure, we 
applied the popular kernel of the radial basis function. All SVM parameters were 
optimized by a grid search (c=2
-10~-1
, g=2
-12~-3
, and p=2
-5~-2
). For each grid point of the 
triplets (c, g, and p), a five-fold cross-validation procedure was employed to evaluate the 
performance of the trained SVM model. To carry out the five-fold validation procedure, 
we ran pair-wise similarity comparison to the training dataset. The total of 4925 positive 
epitopes were split into five groups, and any two-epitope sequences from two different 
groups did not have sequence similarity more than 20%. At each triplet point, the F-
measure was calculated as shown in equation (4). F-measure quantifies a tradeoff of 
sensitivity and precision in prediction performance. The optimal parameter set has the 
largest value in all points with the maximum F-measures. During the procedure of five-
fold cross-validation, five test results were used to calculate the mean values and 95% 
confidence intervals of sensitivity, precision, and the maximal F-measure.  
To optimize the parameter set during the process of SVM training, the three 
performance statistics, sensitivity, precision, and F-measure as defined in Equation (4) 
were used as the major criteria. Sensitivity, also called recall, is used to check the 
proportion of true B-cell linear epitopes identified as positives from all actual positives. 
Precision represents the proportion of true positives from the predicted linear B-cell 
epitopes. These two statistics are of the most interest of immunologists when predicting 
linear B-cell epitopes. However, they showed different trends with the change of SVM 
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parameter sets. One example is shown in Figure 2.2. During our training, when 
decreasing the value of g (parameter γ of the radial basis function kernel) precision would 
go down while sensitivity would go up.  Therefore, to determine the optimal g value, we 
can select g value from the cross point in the graph. the optimal parameter set is decided 
by the maximization of F-measure.  
We also attempted different types of kernel functions in SVM
light
, such as linear, 
polynomial, and radial basis. The final kernel in our models focused on the radial basis 
function after comparing their performance. 
 
 
Figure 2.2 Curve of precision and sensitivity with different g values in SVM 
classifier training. g is parameter γ of the radial basis function kernel. The blue curve 
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stands for precision and the gray curve for sensitivity. Usually, the maximum F-measure 
can be found at the cross point of two curves where a optimal g parameter is determined. 
2.4.2 Statistical Evaluation  
To evaluate the prediction performance of linear B-cell prediction tool, 
performance statistics including sensitivity (Sen), specificity (Spe), precision (Pre), 
accuracy (Acc), Mattews correlation coefficient (MCC), and F-measure (F) are calculated 
by Equation (4) below, 
                                (4)             
where TP, TN, FP, and FN stand for true positive, true negative, false positive, and false 
negative, respectively. All of calculations above are based on five-fold cross-validation 
procedure. 
Another statistical measure, AUC, is also calculated. AUC is the "area under the 
curve" where the curve is a receiver operating characteristic (ROC) curve. In the ROC 
curve, sensitivity, sometimes called TPR (True Positive Rate), is plotted against FPR 
(False Positive Rate), i.e. FPR = FP / (FP + TN). A higher AUC score represents higher 
,
Sen+Pre
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F
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prediction performance. A java program available at 
http://pages.cs.wisc.edu/~richm/programs/AUC/ was used to calculate the AUC.  
Although higher AUC values mean better prediction performance, the 
significance of two AUC score difference must be considered, too. Not significantly 
different AUCs mean that the two classifiers show equal performance when classifying 
unknowns. The online tool StAR was used to test whether the difference between ROC 
curves resulting from two models was statistically significant (40, 41). 
2.5. Online Prediction Tool  
We have also released an online tool for public use. The online tool SVMTriP is 
available on online (http://sysbio.unl.edu/SVMTriP). The major architect of this tool is 
shown in Figure 2.3. In the SVMTriP website, the online prediction tool contains three 
parts, 1) the identified optimal models based on SVM training with carefully-selected 
parameter sets; 2) a database used to store the requests from customers and the final 
prediction results after SVM classification by optimal models; and 3) a background 
server that implements the key process of SVM classification. The technologies involved 
in the SVMTriP online tool include Perl scripts, PHP, and My-SQL database. Blast 
Converting is applied to initial search of protein candidate in known epitope training 
dataset. 
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Figure 2.3: The illustration of the SVMTriP online tool 
For the application on the online server, the prediction model is obtained by 
training SVMs using the datasets as described in the previous sections. To predict 
epitomes from a given full-length protein sequence, the sliding window method is 
employed to obtain subsequences with variable window sizes including 10AA, 12AA, 
14AA, 16AA, 18AA, and 20AA with a step size of 2AA. For each subsequence, 
SVMTriP calculates its score, and a positive score indicates that the subsequence is a 
putative antigenic epitope. Based on the testing results, 20AA was set as the default 
epitope length for SVMTriP to search for putative epitopes on the web server. 
3. Results  
3.1 Prediction performance 
SVMTriP is trained and tested with different epitope lengths, and for each length, 
the SVM parameters have their independent optimal values. For example, for 20AA-
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length cases, SVMTriP reaches its optimal performance at c=32, g=0.05, and p=0.5 for 
the SVM model with Sn=80.1%±2.1% and P=55.2%±1.0% at the point with the maximal 
F-measure, 0.693. All results are shown in Table 2.3. Though, for different lengths of 
epitope sequences, SVMTriP has various points with the maximal F-measure, the 
precision values for different lengths are similar. The sensitivity increases significantly as 
the length of the epitope sequences increases. The range of the values of areas under the 
receiver operating characteristic curves (AUC) is from 0.674 to 0.702. Based on results of 
the performance assessment, SVMTriP for 18AA- and 20AA-length cases have the best 
performance. However, one may note a fact that most of experimentally determined 
epitopes from IEDB have less than 20 AA residues. A possible reason why SVMTriP 
favors long length of sequences is that a long sequence may have more tri-peptides to 
show a detectable frequency tendency. Another possibility is that the epitopic amino acid 
residues in experimentally determined epitopes are subsets of all real epitopic residues. 
Based on the testing results, 20AA is set as the default epitope length for SVMTriP to 
search for putative epitopes on the web server. 
3.2 Comparison with AAP and BCPred 
For comparison, AAP and BCPred are implemented locally based on their method 
descriptions, trained/tested with the same dataset and the five-fold cross-validation 
procedure for 20AA case. The results are listed in Table 2.4. Compared with BCPred and 
AAP, SVMTriP has a similar precision value, but significantly improved sensitivity at the 
point with the maximal F-measure. Figure 2.4 shows the ROC curves for the three 
methods. One may notice that SVMTriP has significantly larger sensitivity than BCPred 
and AAP in the region of low false positive rate. The AUC values are 0.667, 0.667, and 
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0.702 for AAP, BCPred, and SVMTriP, respectively. The AUC value of SVMTriP is 
significantly higher than those from the other two methods; the p-values of comparison 
against AAP and BCPred are 2.17×10-5 and 1.58×10-5, respectively.  
Table 2.3 Performance of SVMTriP models with different epitope lengths 
Length (AA) Sn (%) P (%) F-measure AUC 
10 68.5 ± 2.5 55.5 ± 1.5 0.615 ± 0.020 0.674 
12 67.5 ± 3.5 57.0 ± 2.0 0.620 ± 0.030 0.681 
14 64.8 ± 4.9 56.5 ± 2.5 0.605 ± 0.030 0.689 
16 63.5 ± 5.5 57.1 ± 3.0 0.601 ± 0.045 0.685 
18 79.0 ± 1.9 54.1 ± 1.1 0.641 ± 0.015 0.666 
20 80.1 ± 2.1 55.2 ± 1.0 0.693 ± 0.060 0.702 
 
Table 2.4 Performance of different linear B-cell epitope prediction methods 
Methods Sn (%) P (%) F-measure AUC 
AAP* 59.8 ± 0.9 58.5 ± 6.5 0.590 ± 0.040 0.667 
BCPred* 54.0 ± 7.1 60.5 ± 2.5 0.572 ± 0.055 0.667 
SVMTriP 80.1 ± 2.1 55.2 ± 1.0 0.693 ± 0.060 0.702 
*
The results for AAP and BCPred, are obtained by the software implemented locally. 
 
43 
 
 
 
 
Figure 2.4 ROC curves for AAP, BCPred, and SVMTriP  
4.  Discussion  
4.1 Determination of Different Models 
The determination of linear B-cell epitope prediction models relies on different 
factors. The first consideration is the length of epitopes. The range of epitopes 
determined experimentally usually varies from 5 to 30AA. The optimal length of B-cell 
epitopes for computational prediction is unknown. Results obtained by ABCpred 
suggested the epitope length in statistical models should be no more than 20AA (14). In 
this study, we set up individual models with different epitope lengths. Another factor is 
the combination of features used in models. The optimal combination of features is also 
not clear. Based on different training datasets, the optimal feature set in different linear 
B-cell epitope prediction models may be quite different. Hence, in this study, we also 
determined the optimal combination of specific features with statistical evaluation. 
44 
 
 
 
The optimal window size for linear B-cell epitope is yet another unknown. We 
noticed that among the reported linear B-cell epitopes, over 60% were with the length of 
12-18AA. During the process of learning, there can be a minor deviation between the 
optimal window size for prediction and the average length of real linear B-cell epitopes. 
For example, the function of B-cell linear epitopes is potentially influenced by the 
neighboring residues. Hence, a longer sequence segment embedding linear epitopes may 
contain more useful information. Therefore, in our learning procedures, we attempted 
various lengths of slide window, including 10AA, 12AA, 14AA, 16AA, 18AA, and 
20AA.  
Our training showed the optimal model came from the combination of tri-peptide 
score matrix and tri-peptide subsequence propensity. The hydrophobicity and predicted 
secondary structure scales did not contribute to final model SVMTriP. The optimal 
SVMTriP model was based on tri-peptide score matrix and tri-peptide subsequence 
propensity.  
4.2 The Influence of Different Kernels on SVMTriP Models 
4.2.1 Prediction with tri-peptide propensity alone 
The propensity of tri-peptide alone is tested and the result is shown in Table 2.5. 
The prediction sensitivity is 56.5%, which is little smaller than 59.8% of AAP, a method 
based on bi-peptide propensity. On the other hand, the precision of tri-peptide propensity 
is 61.0%, which is similar with AAP‟s precision of 58.5%. This result indicates that 
combining similarity scores is essential for the tri-peptide model to achieve a better 
performance. 
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4.2.2 Prediction with tri-peptide similarity alone 
The tri-peptide similarity scores can be calculated with either Blosum62 or 
PAM160 matrixes (the results of Blosum and PAM metrics are not shown here). The 
performance of two different matrices for the tri-peptide model is evaluated with the 
same procedure of the five-fold cross-validation for 20AA-length epitopes. The results 
are shown in Table 2.5. Without the propensity score, using Blosum62 matrix shows 
similar performance as using the PAM160. However, when combined with the propensity 
score, Blosum62 matrix leads to a higher prediction performance. 
4.2.3 Discrete tri-peptide subsequence models 
We also implement a method that uses the space of tetra-peptide subsequence 
with one mismatch, i.e., discrete tri-peptide subsequences. For this case, the 
subsequences are considered in patterns either A_AA or AA_A, where „A‟ represents the 
amino acid residue to be considered and „_‟ represents the residue position that will be 
ignored in the comparison. The number of SVM attributes is still 20
3
, which is identical 
to that of the tri-peptide model. Interestingly, as shown in Table 2.5, without considering 
propensity scores, the subsequence models of A_AA and AA_A patterns have similar 
sensitivity and precision with the tri-peptide model. However, the combination of 
similarity and propensity of the tri-peptide model significantly enhances the performance, 
while addition of the propensity does not increase sensitivity and precision for A_AA and 
AA_A patterns. This finding indicates that the propensity is more important for the tri-
peptide model than the discrete tri-peptide subsequence model.  
Table 2.5 Comparison among the tri-peptide subsequence models with or without 
propensity 
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Kernels Sn (%) P (%) F-measure 
Tri-peptide Propensity only N.A. 56.5 ± 12.5 61.0 ± 6.3 0.584 ± 0.085 
Tri-peptide 
w./o. Propensity 
Blosum62 54.5 ± 6.5 60.5 ± 1.5 0.573 ± 0.035 
PAM160 55.0 ± 7.2 61.1 ± 1.8 0.578 ± 0.040 
w./ Propensity 
Blosum62* 80.1 ± 2.1 55.2 ± 1.0 0.693 ± 0.060 
PAM160 69.3 ± 10.0 58.5 ± 3.5 0.633 ± 0.050 
AA_A 
pattern 
w./o. Propensity 
Blosum62 54.8 ± 6.8 60.5 ± 1.5 0.579 ± 0.040 
PAM160 55.2 ± 7.1 61.3 ± 2.0 0.577 ± 0.045 
w./ Propensity 
Blosum62 60.5 ± 5.5 57.5 ± 2.5 0.589 ± 0.040 
PAM160 59.5 ± 5.5 57.5 ± 1.5 0.585 ± 0.035 
A_AA pattern 
w./o. Propensity 
Blosum62 55.5 ± 8.5 60.6 ± 2.2 0.581 ± 0.050 
PAM160 55.2 ± 8.1 60.5 ± 1.5 0.577 ± 0.055 
w./ Propensity 
Blosum62 60.5 ± 6.5 57.5 ± 1.5 0.590 ± 0.040 
PAM160 59.5 ± 5.5 57.5 ± 1.5 0.585 ± 0.025 
*
 The parameter set with Blosum62, Tri-peptide, and propensity were chosen to 
determine the optimal model of SVMTriP 
 
4.2.4 Top weighted tri-peptide 
The prediction model relies on the occurring-frequency distribution of tri-peptides 
in the tri-peptide space, i.e., all combinations of any three amino acids. In Table 2.6, tri-
peptide with top 20 weights in the optimal SVM model of 20AA-length epitopes are 
listed. All of the top ranked tri-peptides contain Glutamine or Proline, whereas the 
occurring frequencies of Glutamine and Proline in known linear epitopes (20AA) are 
only 8.1% and 6.84%, respectively. In the background of overall proteins, the occurring 
frequencies of Glutamine and Proline are 3.84% and 3.44%, which is not significantly 
different to the values in linear epitopes. The tri-peptide containing Glutamine or Proline 
may play an important role in epitope recognition by B-cell antibodies. The algorithm of 
SVMTriP successfully utilized this difference to distinguish linear epitopes from other 
parts of protein peptides. 
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Table 2.6 Weights of tri-peptides in the optimal SVM model 
Tri-peptide Rank Weight Score*  Tri-peptide Rank Weight Score* 
QQP 1 503251.79  GQQ 11 121677.62 
PQQ 2 488627.71  QPY 12 116598.60 
QPQ 3 367386.40  YPQ 13 113237.37 
QPF 4 246462.39  QQF 14 81709.59 
FPQ 5 234868.65  PYP 15 79191.37 
PQP 6 231353.73  FQQ 16 77357.97 
QGQ 7 153161.76  PPP 17 76320.05 
PFP 8 151840.02  QPP 18 64756.05 
QQQ 9 128930.20  QFP 19 63814.16 
QQG 10 122291.90  PPQ 20 63173.33 
*
Weight scores are calculated by the formula w =∑αixi. Here αi is dual representation 
of the decision boundary; and xi (i=0, 1, 2…n) is vector described in SVM model. Both 
αi and xi are available in the model file. 
 
4.3 Independent Test to Compare SVMTriP and Other Linear B-cell Epitope 
Prediction Tools  
Another independent test was developed as a tendency test between virus and 
human proteins by BCPred, AAP, and SVMTriP. Independent testing of different epitope 
prediction methods is challenging because of the limited number of known epitopes. In 
this study, we devise an alternative independent test method. In the training set, most 
epitopes are from virus or bacteria, and their corresponding antibodies are mainly human 
antibodies. A basic property of the human immune system is the capability to distinguish 
any pathogenic agents, viral or bacterial, from the innate structures of the human being. 
All known B-cell epitopes in the training set came from the response of whole immune 
system, including the response of CD4 T helper cells. Trying to simulate the human 
immune system, a successfully trained epitope prediction method should act the same, i.e., 
be able to distinguish pathogenic proteins from human proteins. In other words, the virus 
proteins should be preferentially more highly scored than human proteins by a successful 
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prediction algorithm. To implement this test, 105 20AA-length peptides are collected 
from virus and human proteins: 5×10
4
 peptides are randomly selected from 391,466 virus 
proteins and others from 81,967 human proteins in the NCBI Refseq protein database. 
AAP, BCPred, and SVMTriP are applied to these virus and human peptides, and top-
ranked peptides are returned. The fractions of virus peptides in different numbers of top-
ranked peptides are shown in Figure 2.4. All three methods returned more virus peptides 
than human peptides within the top-ranked peptides. SVMTriP, however, selected higher 
percentage of virus peptides than both AAP and BCPred. For example, in total 400 top-
ranked peptides returned by SVMTriP, 90.5% of them, i.e. 362, are virus peptides. There 
are 47.8% (191) and 56.5% (226) virus peptides returned by AAP and BCPred, 
respectively. This indicates the exceptional ability of SVMTriP to distinguish epitopic 
and non-epitopic peptides. 
 
Figure 2.4 Tendency test for BCPred, AAP, and SVMTriP. Three bars at the same 
point on the x-axis are the results for APP (blue), BCPred (green), and SVMTriP (red), 
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respectively. In the same bar, the light part is for the number of returned human peptides, 
and the dark part is for virus. For example, at the point of 400 returned peptides, the dark 
part in the red bar is 362, which means that 362 viral peptides are return in all 400 
peptides by SVMTriP, and the light red part represents 38 human peptides. 
4.4 The Challenge of Linear B-cell Epitope Prediction 
Although the prediction of linear B-cell epitope has achieved some success, we 
are still not fully satisfied with currently available tools. One of major issues is still rather 
high false positive rates. The main reason is that antibody-binding sites on antigens are 
much less conserved than other types of binding sites. The predator-prey game between 
antibody and antigen has changed the triumphal side many times during the evolutionary 
history. Antigen tried to avoid the recognition and clearance by antibody by changing its 
active sites, while antibody does all the best to figure it out and bind to the antigen. As a 
consequence, the binding sites on antigen, i.e., epitopes, show less conservation and 
lower sequence similarity. At present, almost all of linear B-cell epitope prediction tools, 
including SVMTriP, are based on the assumption of conservation and sequence similarity 
among known linear B-cell epitopes. This is a dilemma between evolutionary immune-
pressure and computational algorithms. One possibility is that B-cell antibodies show 
certain favorite binding pattern on antigen considering their special Y-shapes. 
Another uncertainty in these available prediction tools is from the training 
datasets used. Obviously the datasets are of vital importance for prediction performance. 
The known linear B-cell epitopes mostly were determined by well-designed experiments. 
However, such experimental determination is slow and fund-consuming. Moreover, these 
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experiments usually focus on specific disease-related antigens which people are more 
interested in. The bias in datasets used for training linear B-cell epitope prediction 
methods influences the identification accuracy. With a limited number of available linear 
B-cell epitopes, Blythe and Flower (42) showed that propensity based methods cannot be 
used reliably for predicting B-cell epitopes, which could only yield success rate 
marginally better than random prediction. A bigger non-redundant dataset should be one 
of key factors in future development of improved linear B-cell epitope prediction 
methods. 
We also compare the specificity of linear B-cell epitope prediction compared to 
other protein-protein interaction prediction. For example, given the interaction between 
antibody and antigen is usually transient non-obligate, the binding tends to be one kind of 
rather weak interaction (43). It means that residues of antibody and antigen proteins are 
involved in temporary and unstable adjacency. Special properties of these residue-residue 
bonds potentially affect the performance of algorithms which based on conserved and 
stable residue-residue interaction, such as some protein-protein binding site prediction 
tool (44). Hence, it is difficult to simply use prediction methods for regular protein-
protein interaction in epitope prediction. 
We developed a new method, SVMTriP, to predict linear antigenic epitopes. 
Applied to non-redundant B-cell linear epitope data extracted from IEDB, SVMTriP 
achieves a sensitivity of 80.1%, a precision of 55.2%, and AUC of 0.702 with five-fold 
cross-validation. The combination of similarity and propensity of tri-peptide 
subsequences can improve the prediction performance for linear B-cell epitopes. 
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Moreover, SVMTriP is capable of recognizing viral peptides from human protein 
sequences effectively.  
The SVMTriP website collects the queries from users and stores them as the job 
queue in the database. The local service checks these queries and completes the searching 
along the input antigen sequence one by one. The predicted linear B-cell epitopes will be 
stored in the database and sent to the Result webpage. Generally, under a normal job load, 
a complete search on 200AA-length antigen needs about 20 minutes. 
On the SVMTriP website, we also released the training dataset extracted from 
IEDB database as of June 11
th
, 2012 (http://sysbio.unl.edu/SVMTriP/download.php). 
This dataset is a non-redundant linear B-cell epitope set containing 4925 entries. For each 
entry, we obtained the real epitope segments and the full-sequence of the corresponding 
antigen. We extended or subtracted real epitope segments to construct 10AA, 12AA, 
14AA, 16AA, 18AA, and 20AA subset. These datasets may be used to similar model 
training for new B-cell linear epitope prediction tools using other training features or 
algorithms.  
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CHAPTER THREE: PREDICTION OF CONFORMATIONAL B-
CELL EPITOPES 
1.  Introduction 
Conformational B-cell epitopes are discontinuous segments along antigen 
sequence and they are responsible to the interaction between antigen and antibody. A 
conformational epitope is usually composed of several shorter antibody-binding regions 
physically separated on antigen sequence. Therefore, a conformational B-cell epitope can 
be considered as the union of multiple distinct shorter linear B-cell epitopes.  These short 
linear B-cell epitopes are located independently on the surface of antigen. Therefore, it is 
also possible each of these linear epitopes belongs to different chains of the antigen if a 
quaternary structure of multiple polypeptide chains exists in the antigen protein (1, 2). 
The distribution of subunits of conformational B-cell epitopes gives a hint for the 3D 
structural shape of the entire antigen protein. Determining conformational B-cell epitopes 
approximately equals to identifying the binding surface structure of antigen proteins. 
Usually in the process of identification conformational B-cell epitopes experimentally, 
resolving 3D structures of antigen proteins is the primary strategy. Protein 3D structures 
can be determined by the nuclear magnetic resonance (NMR) or the X-ray 
crystallography, both highly time-consuming. In the Protein Bank Database, therefore, 
there is only a very limited number of structures of antigen-antibody complexes (3).  
Although accurate prediction of antigenic epitopes is needed for immunological 
research and medical applications, it is still a challenging task. Prediction of 
conformational B-cell epitopes seems more difficult so currently there are only a few 
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such methods available. The lack of 3D structures of antigens is the main barrier. Without 
3D structural information of antigen binding to antibody, it is difficult to identify 
discontinuous subunits of conformational B-cell epitopes and to construct a positive 
training dataset for prediction methods. As we discussed, the reliable and unbiased 
positive training dataset is the key for the success of conformational B-cell epitope 
prediction. All discontinuous epitope prediction methods require the three-dimensional structure 
of the antigenic protein. The small number of available antigen-antibody complex structures 
limits the development of reliable discontinuous epitope prediction methods and an unbiased 
benchmark set is very much in demand (4, 5). 
Although discontinuous epitopes dominate most antigenic epitope families (6), 
due to their computational complexity, only a very limited number of prediction methods 
exist for discontinuous epitope prediction". It also reads much better. Currently only 
several conformational B-cell epitope prediction tools are available: CEP (7), DiscoTope 
(8), BEpro (PEPITO) (9), ElliPro (10), SEPPA (11), EPITOPIA (12, 13) and EPCES (4), 
and Bpredictor (14). Due to unsatisfactory performance of currently available methods, 
we developed new tools aiming to improve prediction reliability of conformational B-cell 
epitopes. In this section, we introduce an antigenic Epitope Prediction method by using 
Support Vector Regression (EPSVR) with six attributes: residue epitope propensity, 
conservation score, side chain energy score, contact number, surface planarity score, and 
secondary structure composition. With an independent test dataset, we compare EPSVR 
against other conformational B-cell prediction tools. EPSVR and its related resources are 
available on http://sysbio.unl.edu/EPSVR.  
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The idea of consensus results to improve confidence of prediction is popular in 
bioinformatic research. For example, ensemble method for gene prediction may integrate 
multiple single predictions. Among known conformational B-cell epitope prediction tools 
released, most of them have their own biased results due to its specific training datasets. 
To decrease the biased influences, a meta server can be used to obtain a consensus output 
from multiple prediction tools.  
The success of the meta server also depends on the prediction performance of 
each member. We first consider the prediction performance of each method reported in 
literatures. The attributes used in prediction must be taken into consideration. Prediction 
would be biased if some attributes are used repeatedly in multiple methods. We also have 
to pay attention to the training sets used in those tools. Use of similar training datasets in 
multiple tools may cause bias in prediction. A good meta server should include methods 
based on a wide range of training sets. Finally, the availability of tools is also a 
requirement if we want to install it locally or obtain the results online for further 
consensus analysis. For example, because CEP tool is no longer available online, we 
removed it from our candidates. Similarly, we did not include ElliPro because it was not 
available for download. 
Our EPmeta server incorporates EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO, 
and Discotope1.2. Prediction is done by each tool individually first. The outputs from the 
six tools are combined together to generate a single consensus output. With an 
independent test dataset, EPmeta showed a more confident prediction than its each 
member. The EPmeta server is available at http://sysbio.unl.edu/EPmeta. 
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2. The Development of Novel Conformational B-cell Epitope Tool, EPSVR 
2.1 Dataset collection 
a) Training Dataset 
        The training set was gathered and screened from three protein datasets: 1) 22 
antigen-antibody complexes and their unbound structures from protein docking 
Benchmark 2.0 (15); 2) 59 representative antigen-antibody complexes compiled by 
Ponomarenko and Bourne (5); 3) 17 antigen-antibody complex structures released 
between February 2006 and October 2008 with available unbound antigen structures, 
which was the test set use in EPCES server (4). Any antigen-antibody complex was 
discarded if its antigen had no available unbound structure because the unbound 
structures were required for prediction. A complex structure was not used if its antigenic 
epitope consisted of amino acid residues located on multiple chains. A complex was 
included if the sequence identity between its antigen and all other antigens from the other 
complex structures was less than 35% following local sequence alignment. For an antigen 
with a sequence identity in the range of 35~50%, we accepted the antigen-antibody 
complex if the binding topology was not the same as its homologous complex. For an 
antigen with more than one antigenic epitope, only one was used in order to avoid 
confusion in subsequent application of support vector regression methods. As a result, a 
total of 48 complexes and their unbound structures meeting the above criteria were used 
as a training set. 
b) Testing Dataset 
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The test set was curated from 293 entries of the Conformational Epitope Database 
(CED, Release 0.03) with the following criteria (16). We only considered entries that had 
unbound antigen structures, but no complex structures. Multiple entries with the same 
antigen structure were combined and considered as one target, and antigenic residues 
from multiple entries were mapped onto one protein structure. The sequence identity 
between any two selected proteins was also required to be less than 35%. All selected 
antigens were also screened against the rest of CED database and our training set; the 
sequence identity between a selected antigen and other antigens with complex structures 
in the CED or in the training set was less than 35%. A total of 22 antigenic proteins in the 
CED met all the above criteria; these were: 1www, 1hgu, 1eku, 1mbn, 1av1, 1pv6, 1al2, 
2gmf, 1a7c, 1y8o, 1og5, 1jeq, 1dab, 1w7b, 1ly2, 1rec, 1nu6, 2b5i, 2gib, 1p4t, 1xwv, and 
1qgt.  Three antigenic proteins, 1www, 1hgu, and 1xwv, were excluded since they had 
multiple antibody-binding sites and the mapped antigenic residues were evenly 
distributed on the protein surfaces. Therefore, the final test set contained 19 antigen 
structures. 
2.2 Attributes 
    Six attributes were used to antibody binding site prediction.  
a) Epitope propensity 
    Epitope propensity at the amino acid position i, Epropensity (i), is defined as 
Epropensity (i) = (ln
Pr
interface
Pr
surface
)´
Sr
Sr
ave
     (1) 
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where Pr
interface
 and Pr
surface 
represent the probabilities of residue type r located on 
antibody-binding interface or just on the surface of antigen protein, respectively. They 
were calculated based on the residue types from the antigen proteins in the training set. 
All of epitopic residues were considered to be at the antibody-binding interface. 
Parameters Sr and Sr
ave
 are the relative accessible surface area of residue r at the sequence 
position i and the average relative accessible surface area of surface residues of type r, 
respectively. The Cα atom of Gly is considered as a side chain atom for convenience (17). 
Since antigen-antibody interfaces have different residue composition compared with 
other protein-protein interfaces, we used the training dataset to derive residue-specific 
antibody binding site propensities in epitopes and background proteins.  
b) Conservation score 
      A residue conservation score relies on position-specific substitution matrix 
(PSSM), which is obtained by three rounds of searches using PSI-BLAST (18) starting 
with the BLOSUM62 substitution matrix. The conservation score at the position i is 
defined as 





00
0
   - B, if M
,  - B|, if M - B|M
 (i)=E
rrir
rrirrrir
conserv     (2) 
where Mir is the position-specific score in PSSM for the residue type r at sequence 
position i, and Brr is the diagonal element of BLOSUM62 for residue type r. 
Conservation score is set to 0 if the position-specific score after three rounds of PSI-
BLAST search is larger than the original position-specific score in BLOSUM62 (17). As 
we discussed in chapter two, epitopic residues show lower conservation than other 
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functional residues of most of non-antigenic proteins. In contrast to regular protein-
protein interaction where conserved surface residues in the unbound structure are 
considered as interface residues, the poorly conserved residues of antigen are considered 
as the putative antibody-binding site residues due to adaptive evolutionary pressures for 
antigen proteins. 
c) Side-chain energy score 
       Side-chain energy can influence protein structural conformation and further 
function on the spatial context of protein surfaces. Side-chain energy score is calculated 
from the side-chain energies of all possible rotamers for a given residue type at a 
sequence position whereas other sequence positions have native residue types and 
observed atomic coordinates. The weights of the energy function are optimized so that 
the native residue was predicted energetically favorable at each position of the training 
proteins. The assumption is that the residues at the antibody binding site have a higher 
energy score than other surface residues so that the free energy of the antigen-antibody 
system could go down significantly upon association. 
       The definition of side-chain energy score was given in Liang and Grishin (19). 
The energy unit is kcal·mol
−1
. The side-chain energy score of amino acid i is defined as, 
Eside chain (i) = - f  ln exp -Eside chain (Ri )[ ]
R
å{ }     (3) 
where the summation is over all the rotamers available for a given residue type and the 
constant prefactor f = 1/2.41, which is from the slope of the regression line between the 
calculated and experimentally measured unfolding ΔΔG of a set of point mutation data.  
Ri is a given rotamer of residue i and Eside chain (Ri) is defined as,  
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Eside chain (Ri ) = - 0.143 Scontact  + 0.724 Voverlap + 1.72 Ehbond + 28.6 Eelec  
- 0.0467Spho + 0.0042Sphi + 1.14 (Fphi )
30 + 7.95 Vexclusion - 0.919 ln(f1 f2 ) 
- 4.3 Nssbond - Gref
 (4) 
where Scontact, Voverlap, Ehbond, Eelec, ΔSpho, and ΔSphi represent atom-contact surface area, 
overlap, H-bond energy, electrostatic interaction energy, buried hydrophobic solvent 
accessible surface, and buried hydrophilic solvent accessible surface between the rotamer 
of residue i and the rest of protein, respectively. Fphi, Vexclusion, Nssbond, and ΔGref are 
defined as the fraction of the buried surface of non-hydrogen-bonded hydrophilic atoms, 
the normalized solvent exclusion volume around charged atoms, the flag of disulfide 
bridge(1 or 0), and the difference between the free energy of the rotamer in solvent and 
denatured protein, respectively. f1 is the observed frequency of the rotamer and f2 is the 
observed frequency of the amino acid residues in a given backbone conformation.  
d) Contact number 
       The residue contact number is the number of Cα atoms in the antigen within a 
distance of 10 Å of the Cα atom of residue i (8). A residue with a small contact number 
was considered as an antibody binding site residue. 
e) Surface planarity score 
      The planarity of each surface patch was calculated by evaluating the root mean 
squared deviation (rmsd) of all the Cα atoms in the surface patch from the least squares 
plane through the atoms. The rms deviations were inverted such that a high planarity 
score for a patch was interpreted as a planar patch and antibody binding site (20). 
f) Secondary structure composition 
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This score was defined as the fraction of patch residues forming turns or loops in 
all 20 patch residues. Based on Chou and Fasman's method (21), the α-helix and β-sheet 
were defined as four or more consecutive residues having φ and ψ angles within 40° of (-
60°, -50°) and three or more residues having φ and ψ angles within 40° of (-120°, 110°) 
or (-140°, 135°), respectively. The remaining regions were considered turns and loops. 
2.3 Training Procedure for EPSVR 
For each surface patch, the number of epitopic residues could be any integer value 
between 0 and the patch size (20 for this study), and each surface patch had six Support 
Vector Regression (SVR) attributes as described above. The residue epitope propensity, 
conservation score, and side-chain energy score were calculated at the residue level and 
averaged over all residues in the patch. The six scores and the number of observed 
epitopic residues in the patch were scaled to 0~1.  
All SVR parameters were optimized by a grid search (c = 2
-10~-1
, g = 2
-12~-3
, and p 
= 2
-5~-2
) where c is trade-off between training error and margin, g is parameter gamma for 
radial basis function kernel, and p is the fraction of unlabeled examples to be classified 
into the positive class (22); and for each grid point of triplets, a leave-one-out procedure 
was applied to evaluate the trained SVR model. Specifically, the patch score of each 
surface patch for a target in the training set was predicted by the SVR model trained with 
the other 47 antigen-antibody complexes, from which the residue epitope propensity 
score was also derived. After this procedure was repeated 48 times, the mean AUC value 
of 48 predictions represents the performance of the current grid point for SVR parameters. 
The triplet of parameters that reached the highest value of mean AUC was chosen and 
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used for the test set, and the final support vector machine model was trained with all 48 
targets. 
2.4 Prediction Procedure for EPSVR 
A surface patch is defined as a central surface residue and its 19 nearest surface 
neighbors in space, where a surface residue is defined if the relative accessibility of its 
side chain is greater than 6% with probe radius = 1.2Å. First, we searched for all surface 
residues and enumerated all surface patches of a given antigen structure, and calculated 
their six SVR attributes. For each surface patch, we predicted the number of putative 
epitopic residues by the trained SVR model. Here, a patch score was defined as the 
fraction of the number of putative epitopic residues to the total number of amino acid 
residues in the patch, i.e., 20. One surface residue was assigned a residue score by 
averaging patch scores of all patches in which this amino acid residue is included. Finally, 
we sorted surface residues according to their residue scores and the top-ranked ones were 
considered as epitopic residues. The assumption here is that a residue frequently 
appearing in top- scoring patches is likely an epitopic residue. 
Patch analysis was used in all existing B-cell discontinuous epitope studies. In the 
examples of EPCES and EPITOPIA, a patch score was derived by averaging the scores 
of all residues in the patch, and the central residues of top scored patches were predicted 
as epitopic residues. However, the value of the patch score was actually correlated with 
the number of epitopic residues in the patch rather than the central residue. Here, we used 
SVR to predict the number of epitopic residues in a surface patch and residues frequently 
located in the top scored patches were predicted as epitopic residues. For this case, the 
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SVR model is more suitable than a support vector classifier. In this study, we used an 
SVR package, called LIBSVM, obtained from http://www.csie.ntu.edu.tw/~cjlin/ libsvm. 
2.5 Results 
2.5.1 Prediction for the Training Set for EPSVR 
When c=2
-6
, g=2
-5
, p=2
-3
, the mean value of AUC for the 48 targets in the training 
set reached its maximum, 0.670, in the leave-one-out test. As a comparison, the mean 
AUC value is 0.644 predicted by EPCES, whose residue interface propensity was derived 
from the other 47 targets using the same leave-one-out procedure as described. The 
improvement of EPSVR could be attributed to the machine learning method because 
EPSVR and EPCES used the same six scoring terms.  In another study, Rubinstein et al. 
applied support vector classifier (EPITOPIA) to predict B-cell epitopes and obtained a 
mean AUC value of 0.65 for a similar non-redundant set of 47 antigen-antibody complex 
structures in cross validation (13). Our algorithm showed slightly better performance for 
a somewhat different training set. 
2.5.2 Prediction for the Test Set for EPSVR 
We applied our algorithm, with the optimally trained parameters, to the 
independent test set, and achieved a mean AUC value of 0.597, which was lower than 
that of the training set.  Nevertheless, 6 out of 19 targets were predicted with an AUC 
value greater than 0.7.  Note that the interface residues of antigens in the test set were 
identified by point mutations, overlapping peptides, and ELISA, which are not as 
accurate as the crystal complex structure method. 
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Six antigens in test proteins (1eku, 1av1, 1al2, 1jeq, 2gib, and 1qgt) contained 
multiple chains, but we only used a single chain where the experimental antigenic epitope 
was located for prediction. If the whole protein was used for prediction, the mean AUC 
value of the six proteins decreased from 0.672 to 0.623.  Unlike antigenic epitopes, the 
interfaces of protein-protein complexes, especially non-transient complexes, are usually 
more hydrophobic and conserved than protein surfaces; it makes the exposed protein-
protein interfaces relatively-easily distinguishable from both the antigenic epitopes and 
other protein surfaces. In other words, a single chain protein that has both protein-protein 
binding interfaces and epitope made the epitope prediction task easier. 
3. Development of Conformational B-cell Epitope Meta Tools EPmeta 
3.1 Selection of Conformational B-cell Epitope Prediction Tools 
       Selection of conformational B-cell epitope prediction tools is a key step in 
constructing the meta server. Before EPSVR, there were only a limited number of 
methods available, i.e., CEP (7), DiscoTope (8), PEPITO (9), ElliPro (10), SEPPA (11), 
EPITOPIA (12, 13), and EPCES (4). These tools applied different physicochemical 
properties of epitopes in their corresponding model-training, such as the hydrophilicity 
scale and the epitope log-odds ratios in DiscoTope (8), the epitopic residue propensity 
and the half sphere exposure values at multiple distances in PEPITO (9), residue 
protrusion index (PI) in ElliPro (10), the epitopic residue propensity and the compactness 
of the neighboring residues around one residue in SEPPA (11), forty-four 
physicochemical  and structural–geometrical attributes in EPITOPIA (12, 13), and six 
physicochemical properties used in EPCES (4) and EPSVR (23). These attributes have 
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different effects on determining conformational B-cell epitopes. Hence, in our EPmeta 
server, different servers should have different weights in constructing the consensus 
result. 
3.2 The Architecture of EPmeta 
       An open question for any meta server is how to quickly obtain prediction results 
from multiple tools. One choice is install these tools locally. Local installation requires 
standalone packages. Unfortunately, DiscoTope (8), PEPITO (9), ElliPro (10), SEPPA 
(11), or EPITOPIA (12, 13) cannot provide a standalone package for local installation. 
       With the idea of remote searching technology, a machine-simulation will obtain 
the searching results on web browser through accessing remotely available servers. In 
contrast to using locally installed programs, a meta server can directly access to remotely 
available services, run a query, and download the results from the remote servers. This is 
the strategy used for EPmeta. 
 
Figure 3.1 Architecture of the EPmeta server. 
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3.3 The programming technologies to complete the EPmeta server 
       The main technological blockage in using remote servers is how to communicate 
between the meta server and other online tools. Unfortunately, we solved this issue by 
carrying out a type of machine-simulation  of automated web-browser navigation. Scripts 
can automate completing a series of customized operations on web browsers, such as to 
open a web browser, input a Uniform Resource Locator (URL) address, fulfill the form 
on web page, upload a PDB file (3D protein structures), and download a web source page. 
All the operations including human-like activities with mouse and keyboard in front of a 
computer are simulated. Hence, the meta server does not need an API or a web server to 
communicate with online tools. It just relies on the successful access to the remote 
servers by a web browser, such as Internet Explorer or Firefox. 
        There are many ways to carry out machine-simulated automated navigation of a 
web browser. Similar technologies are applied on automated testing during the 
development of web applications. To decrease human labor on repeated software testing, 
software development engineers in testing (SDET) developed the platform of automated 
testing. For automated testing of web applications, machine-simulated navigation of a 
web browser is one of the fundamental functions of the platforms.  Although many such 
automated testing platforms are commercial products, there are a few open-source free 
platforms on Microsoft Windows with Internet Explorer and fewer on Linux with Firefox. 
In this study, we chose a platform based on a programming language Ruby and the Watir 
platform to our EPmeta. Watir is an open-source free platform providing the Ruby library 
for automating web browsers (http://watir.com/). Using Ruby and Watir, we completed 
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the automated access of online tools by our meta sever and achieved the query on these 
tools.  
      Figure 3.1 illustrates the architecture of the EPmeta server. We choose the six 
tools because their reports showed the best predictions when we prepared EPmeta server 
in 2009. After completing six queries to EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO, 
and Discotope1.2, we generate a consensus result. 
For the Meta server, the basic idea was that a surface residue is predicted as an 
epitopic residue if two or more single servers voted for it. In this naive sense, the mean 
AUC values of the 19 testing proteins was calculated to be 0.562, 0.618, 0.627, 0.621, 
and 0.612 predicted by the top 2, 3, 4, 5, and 6 servers, respectively (Table 3.1). To adopt 
a more sophisticated strategy, the top 25% of surface residues were returned as predicted 
epitopic residues by EPSVR, EPCES, and EPITOPIA. When the number of the predicted 
residues was increased from 25% to 50%, from 50%to 75%, and from 75% to 100%, 
SEPPA, PEPITO, and DiscoTope1.2 were, respectively, included in the voting. For 
example, the new antigenic residues predicted by EPSVR, EPCES, EPITOPIA, and 
SEPPA were added to the top 25% residues predicted by EPSVR, EPCES, and 
EPITOPIA. The prediction started with 1% of the surface residues for each of the four 
servers and increased insteps of 1% until 50% of surface residues were predicted as 
antigenic residues. Then we added PEPITO and used five servers to predict the top 
50%~75% surface residues and so on. With this method, we achieved a mean AUC value 
of 0.638, which is higher than all single servers, especially, Discotope1.2 and PEPITO (p-
value < 0.05). The reason that we used this strategy to integrate the various predictions 
results from our finding that a single server had better prediction accuracy when only a 
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small fraction of the surface residues were predicted as epitopic residues. If 50% of 
surface residues, for example, were predicted as epitopic residues by the Meta server, the 
prediction accuracy was 14.4% for the Meta server with a voting set including EPSVR, 
EPCES, and EPITO-PIA, where each server output the top 51% surface residues as 
candidates of antigenic residues. As a comparison, the prediction accuracy was slightly 
higher (15.3%), if the Meta server also returned 50% of the surface residues as epitopic 
residues, but got votes for those returned residues from all of the six servers, where each 
server output their own top 32% surface residues as candidates of epitopic residues. 
      The following is the final algorithm:  
[ 
BEGIN 
N = the total number of surface residues; 
E = the number of predicted epitopic residues; 
if E ≤25% * N then, 
return Predictor (0, E, EPSVR, EPCES, EPITOPIA);   
else if E > 25%*N AND E ≤50%*N then, 
return Predictor (R25, E, EPSVR, EPCES, EPITOPIA, SEPPA);  // Rp = p% of surface 
residues already predicted as epitopic residues; 
else if E > 50% AND E ≤75%*N then, 
return Predictor (R50, E, EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO); 
else if E > 75% AND E ≤100%*N then, 
return Predictor(R75, E, EPSVR, EPCES, EPITOPIA, SEPPA, PEPITO, Discotope1.2) 
endif. 
 
Function Predictor(Rp,E,SERVER1,SERVER2,SERVER3,...) 
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Begin 
set the prediction of each single server to 0; 
do { 
Increase the prediction of each single server at the step of 1%; 
Collect residues predicted by at least two of the servers; 
} While(Rp + collected epitopic residues other than Rp < E); 
Return total epitopic residues; 
END 
] 
 
3.4 Results 
Although EPSVR and EPCES used the same six scoring terms, we found that it 
was necessary to include both of them in the Meta server.  When we used a voting server 
set including EPCES, EPITOPIA, and SEPPA, i.e. excluding EPSVR, the average AUC 
value decreased to 0.587 for the test set.  The average AUC value predicted by EPSVR, 
EPITOPIA, and SEPPA (0.611) was also lower than that predicted by EPSVR, EPCES, 
and EPITOPIA in the standard procedure (0.618). We also tried to increase the threshold 
of votes from two to three for a voting server set, but the results did not improve. 
4. Discussions 
We introduced a SVR method to integrate six attributes for discontinuous epitope 
prediction and a server, EPSVR, which can be accessed online. The AUC of EPSVR is 
0.597, which is higher than that of any other existing single server. Although they used 
the same scoring functions, EPSVR exhibited improved performance over EPCES. This 
was attributed to the fact that EPSVR searched the six-dimensional parameter space of all 
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scores more broadly than the voting method we previously used. Furthermore, a Meta 
server, EPmeta, combining EPSVR and the other existing single servers together, had an 
AUC value of 0.638, which is higher than any single server, especially, DiscoTope and 
PEPITO. We also found that the use of both EPSVR and EPCES, which use the same 6 
scoring terms, resulted in a higher performance for EPmeta than if only one was used. 
The AUC results for different methods are shown in Table 3.1. 
Table 3.1 List of the Conformational B-cell Epitope Prediction Methods and Their 
Obtained AUC Results 
Method URL of web server AUC 
Accuracy
b
 
(%) 
DiscoTope (8) http://www.cbs.dtu.dk/services/DiscoTope/ 0.567 15.5 
BEpro(PEPITO) (9)  http://pepito.proteomics.ics.uci.edu/ 0.570 17.0 
ElliPro (10) http://tools.immuneepitope.org/tools/ElliPro/iedb_input 0.585 14.3 
SEPPA (11) http://lifecenter.sgst.cn/seppa/index.php 0.576 17.2 
EPITOPIA (12, 13) http://epitopia.tau.ac.il/index.html 0.579 17.8 
EPCES (4) http://sysbio.unl.edu/EPCES/ 0.586 18.8 
EPSVR (23) http://sysbio.unl.edu/EPSVR/ 0.597 24.7 
Bpredictor (14) 
http://code.google.com/p/my-project-
bpredictor/downloads/list 0.598
a
 24.0
c
 
EPmeta (23) http://sysbio.unl.edu/EPmeta/ 0.638 25.6 
a) 
The AUC value is obtained from the Reference (14). 
b)
 10% of surface residues are 
returned as predicted epitopic residues. 
c)
 Estimated based on the Figure 4 in the 
Reference. 
 
To assess and compare prediction performance of these predictors, we carried out 
an independent test by the testing set containing 19 protein monomer structures with 
epitope information derived from experimental methods other than crystal structures. 
AUC score is the major criterion for each method. A receiver operating characteristic 
(ROC) curve represents a dependency of true positive rates (sensitivity) and false positive 
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rates (1-specificity), plotted at various thresholds. To change the thresholds, the number 
of predicted residues is increased in steps of 1% of total surface residues. The mean AUC 
values are calculated using a java program available at 
http://pages.cs.wisc.edu/~richm/programs/AUC/ (24), except for Bpredictor. For 
Bpredictor, the AUC value is directly obtained from the manuscript (14) where the same 
benchmark by Liang et al. (4) was applied as in the current work. Among single servers, 
EPSVR and Bpredictor have the best performance according to the AUC values. 
Although EPSVR has the highest mean AUC value, the differences between EPSVR and 
other servers are not statistically significant (p-value >0.05), according to the pairwise t-
student tests. The Meta server, EPmeta, achieves a mean AUC value of 0.638, which is 
significantly higher than all single servers. 
We also calculated the accuracy by the same independent test because the 
accuracy, i.e. positive prediction rate, is useful for experimental testing. When each 
server returns 10% of surface residues as predicted epitopic residues, the accuracy was 
14.3%, 15.5%, 17.0%, 17.2%, 17.8%, 18.8%, 24.7%, and 25.6% for Ellipro, 
DiscoTope1.2, BEpro (PEPITO), SEPPA, EPCES, EPITOPIA, EPSVR, and EPmeta, 
respectively, as shown in Figure 3.2. The accuracy is around 24% for Bpredictor based 
on Figure 4 in the Reference (14). The rationale of selecting 10% surface residues to be 
predicted as positive is because the average length of antigen proteins is around 200 
amino acids and the average size of epitopic patch is about 20 amino acid residues. The 
current level of accuracy of all predictors is not yet satisfactory. Even the highest 
accuracy, 25.6% achieved by EPmeta, leaves room for further improvement. If 3% of 
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surface residues are returned as predicted epitopic residues, the accuracy of EPmeta is 
31.6%, which is the overall highest value by all conditions and methods. 
 
Figure 3.2 Prediction accuracy of six antigenic epitope prediction servers and Meta 
server on 19 independent testing proteins. Y-axis is AUC score and x-axis is the 
threshold of prediction score. The prediction accuracy was averaged for 19 independent 
testing proteins, except for EPITOPIA because it failed to assign scores for the antigenic 
residues of 1jeq and the prediction accuracy was averaged over the other 18 proteins. 
For the EPmeta server, its architecture of using remote web servers lowers the 
pressure of the local meta server. The computational time is mainly based on the speed of 
online tools and the transferring speed throughout the internet. While with steady internet 
connection, communication between the meta server and online tools is no longer an 
issue, computational time with each online tool is the major time consuming part. Most of 
conformational B-cell epitope prediction tools require more than ten minutes, even half 
an hour, to complete one query for 200-aa sequence. For example, the average computing 
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time for EPITOPIA is over thirty minutes based on our tests accessing from the 
University of Nebraska – Lincoln. The distributed architecture of the meta server allows 
the parallel operations involved in multiple queries to different online tools. Therefore, 
unlike local implementation of different tools, we can run these queries online 
simultaneously and we do not have to care about the machine pressures since these online 
servers are independent. Distributed system has been widely applied for large-scale or 
intensive computation, usually shared among multiple physical machines. 
This distributed architecture also lowers the risk of the EPmeta server for 
installation and maintenance of multiple programs. Since we did not intend to install the 
tools locally, proper installation was not an issue. It is also easier to track the newest 
version of tools by just accessing them directly online. As a result, the distributed 
architecture of the meta server guarantees always the good query of results from different 
tools. 
5. Challenge of Conformational B-cell Epitope Prediction 
In recent years, a number of new conformational B-cell epitope prediction 
algorithms have been developed. While the prediction performance has been improved, it 
is still far from satisfactory. Compared with other bioinformatic problems, antigenic 
epitope prediction is especially difficult due to the lack of properties that are universally 
but uniquely observed for the antigenic epitopes but not for other protein surfaces. 
Additionally, regular binding-site prediction methods are not suitable for antigenic 
epitope prediction because they focus on the conservation of surface residues. 
5.1 Single Chain or Multiple Chains 
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The recognition of antibody to antigenic epitopes has high specificity; the epitopic 
surface is not as conserved as other functional protein binding sites, which comes from 
the conserved functions of protein-protein interactions during evolution. The interfaces of 
regular protein-protein binding are usually more conserved and have more hydrophobic 
amino acid residues than non-binding protein surfaces. This makes the exposed protein-
protein interfaces relatively easy to distinguish from both the antigenic epitopes and non-
binding protein surfaces. In other words, the prediction task for a single chain protein that 
has both protein-protein binding interfaces and an antigenic epitope is easier than that of 
a protein complex.  
In the benchmark dataset, six of the proteins (PDB IDs: 1eku, 1av1, 1al2, 1jeq, 
2gib, and 1qgt) possess multiple chains. Therefore, in our evaluation all methods were 
tested with two different scenarios for these six proteins: prediction on a single chain 
where the experimental antigenic epitope is located and prediction on the whole protein 
including all chains. When multiple chains were examined, all chains were considered, 
and the total number of surface residues was counted for the intact complex structure. As 
a result, some methods, such as EPSVR, showed decreased performance with lower mean 
AUC values for the 6 proteins when the whole protein was used for prediction compared 
with those based on the single chain containing the antigenic epitope. Therefore, in the 
future, if sufficient data exist, a range of test datasets shall be compiled for different cases, 
i.e., single chain antigens, single chains from antigen complexes, and antigen complexes. 
A good antigenic epitope predictor shall have satisfying performance on all types of 
benchmarks.  
5.2 Protein Binding Site Prediction Methods 
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Due to the lack of many epitope prediction methods for analysis and comparison, 
potein-binding site prediction methods are frequently used for conformational epitope 
prediction (5, 25) since epitopic patches can be considered as a type of protein binding 
sites. The methodologies used by protein binding site prediction and epitope prediction 
are similar; both integrate some amino acid scoring functions with a machine learning 
algorithm or other platform to train a prediction model on known data. The major 
difference is their distinct training sets; while protein binding site prediction uses all 
known protein-protein binding complexes, an epitope prediction method is trained with 
antibody-antigen complexes only. Therefore, we also applied the benchmark epitope 
dataset to test some binding site prediction methods. For this we selected binding-site 
prediction methods that have both demonstrated good performance and convenient web 
servers for public use. The AUCs achieved by these methods for the epitope benchmark 
are shown in Table 3.2. One can see that the performances of the binding-site prediction 
methods to predict B-cell epitopes are significantly lower than all conformational epitope 
prediction methods (shown in Table 3.1). This is not surprising because all binding-site 
prediction methods are designed based on the conservation and hydrophobicity of 
binding patches. B-cell epitopic patches are neither conserved nor more hydrophobic 
compared with other protein-protein binding surfaces. Instead, the residues on the 
antigenic epitopes are more diverse than regular surface residues due to the evolution 
pressure from the host immune system. Therefore, we conclude that the general binding-
site prediction methods are not suitable for antigenic epitope prediction. Any epitope 
prediction methods developed in the future is not recommended to claim performance 
improvement by simply compared with binding-site prediction methods.  
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Table 3.2 List of the Protein Binding Site Prediction Methods and Their Obtained 
AUC Results 
Method URL of web server AUC 
ProMate (26) http://bioinfo.weizmann.ac.il/promate/ 0.530 
ConSurf (27) http://consurf.tau.ac.il/index_proteins.php 0.460
a
 
PINUP (17) http://sysbio.unl.edu/services/PINUP 0.562 
PIER (28) http://abagyan.ucsd.edu/PIER/pier.cgi?act=dataset 0.537 
a)
 Conserved residues are selected as for common binding site prediction. 
5.3 Future Directions 
Currently, various sets of attributes and classifiers have been applied by different 
existing epitope prediction algorithms. It naturally leads to one question: which 
combination of attributes is optimal for the prediction? To answer this question, one may 
systematically evaluate different machine-learning algorithms on all non-redundant 
attributes and allocate the optimal set among them. Also of great importance to the 
epitope prediction research is the growth of the training data, especially the antigens that 
have both bounded and unbounded structures. It is also important to collect high quality 
independent testing data, such as the ones compiled by Liang et al. (23), that contain 
experimentally measured epitopic residues but no complex structures. We also 
recommend that all future researchers implement their developed algorithms as free 
accessible web servers or downloadable software packages, because B-cell epitope 
prediction algorithms will likely become more and more complicated and meta-methods 
usually have better prediction accuracy than any of the single algorithms. 
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CHAPTER FOUR: PREDICTION OF EPITOPIC RESIDUES WITH 
PROTEIN SEQUENCES 
1. Introduction  
In the previous chapters, we discussed the two kinds of B-cell epitopes: linear and 
conformational epitopes. It was reported that about 90% B-cell epitopes are 
conformational (1). Therefore, we developed prediction tools for conformational epitopes 
based on known 3D structures of given antigens. However, the small number of solved 
structures of antigens limits the application of our epitope prediction. In this chapter, we 
will tackle this difficulty by developing a new method to analyze antigen protein 
sequences to predict epitopic residues. Currently the study on protein-sequence-level 
prediction of epitopic residues of B-cell epitope is still under development. One possible 
reason is a limited resource of known epitopic residues of B-cell epitope. Another reason 
lies in the complexity of epitope binding patterns. At present, to our knowledge, there are 
a very few epitope-antibody binding patterns reported. So it is still difficult to extract the 
principles of key residues from known epitope-antibody binding patterns. Due to these 
facts, we must find a new way to predict the key residues of B-cell epitopes. 
In chapters two and three, machine learning methods have been proven powerful 
in terms of classification. By the analysis of known B-cell epitopes and non-epitopes, a 
machine learning method draws a border to separate epitopes and non-epitopes. In this 
chapter, we will apply the Support Vector Machine (SVM) as a tool of machine learning 
to predict epitopic residues based on input of protein sequences.  
To set up a training process, the first step is to collect known epitopic residues of 
B-cell epitopes. The immune epitope database (IEDB) contains the updated information 
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of B-cell epitopes most of which are still hypothetical (2). For our study, we employ a 
more reliable way to collect key epitopic residues of antigens. In our study only 3D 
structures of antigen-antibody complexes precisely showing the residues of epitope 
directly bound to antibody are used as the data resource. To construct the positive dataset, 
we have investigated 561 antigen-antibody complexes whose antigens come from 11 
species. For these antigen sequences, we filtered them by a threshold of 30% similarity to 
generate an unbiased dataset. After the similarity filtering, we extracted 2682 key 
residues which come from 134 unique antigens. The details about building the positive 
dataset containing known key epitopic residues are described in section 2.1. 
For each epitopic residue, the subsequence surrounding it with a certain length is 
extracted from the original antigen, and the sequence pattern and physicochemical 
characteristics of any given subsequence are quantified for epitopic residue prediction. 
The sequence pattern and physicochemical properties of these segments include Shannon 
Entropy (SE), Relative Entropy (RE), Position Specific Scoring Matrix (PSSM), 
Predicted Secondary Structure (SS), Protein Disorder (DIS), Solvent Accessible Area, 
Overlapping Properties (OP), Sequence Complexity (SC), and Averaged Cumulative 
Hydrophobicity (ACH). They are considered and optimized as the segment features for 
SVM training in our study. Similar strategy and features can also be applied to the point 
residue prediction, such as the prediction of phosphorylation sites (3, 4). 
In this study, we developed a novel tool, named SVMKER, to predict the epitopic 
residues with an input of a protein sequence only. With carefully designed feature 
characterization of the sequence segments, SVMKER has shown a precision of 59.5% 
and a sensitivity of 52.2% using five-fold cross-validation process. It is the first time that 
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a prediction tool has been developed for epitopic residue prediction at the protein 
sequence level. This tool can provide a preliminary search for epitopic residues on 
antigens before an experimental design.  
2. Materials and Methods 
2.1 Datasets 
The original information about epitopic residues of B-cell epitopes was extracted 
from PDB (5). As of June 2012, we downloaded 561 3D structures of antigen-antibody 
complexes involved in 11 species. From these 3D structures, we extracted 134 low-
similarity antigen sequences with a threshold of 30% similarity. An amino acid residue of 
the antigen is considered as one epitopic residue if it has at least one atom that has less 
than 6 Å distance to any atom of antibody (6). The criterion is illustrated with an example 
in Figure 4.1 below. 
 
Figure 4.1 The distance of atom-atom distance between antigen and antibody. The 
epitopic residue on an antigen must contain at least one atom with less than 6 Å distance 
away from an antibody‟s atom. For example, in the 3D structure of human IgM 
rheumatoid factor Fab bound to its autoantigen IgG Fc (PDB ID: 1ADQ) (7), the amino 
acid residue ASN-384 is considered as an epitopic residue because it contains two atoms 
less than 6 Å from the antibody. The same happens to GLN-386. 
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After identifying all known epitopic residues from the 3D structures of the 
antigen-antibody complexes, we created the positive datasets containing 2682 protein 
sequence segments with epitopic residues in the middle positions. The segment length 
includes 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, and 23 amino acids (AA). Figure 4.2 shows 
protein sequence segments with different sizes. The negative dataset was constructed by 
including the non-redundant segments with the same length of positive dataset segments 
from the sections of antigen sequences where no epitopic residues exist. The total 
numbers of positive and negative segments are 2682 each; the positive and negative 
segment ratio is 1:1. 
 
Figure 4.2 A segment in the positive dataset determined by extending the key 
epitopic residue in both sides along the antigen sequence. 
 
2.2 Attributes 
For a machine-learning technology, we need to quantify the sequence pattern and 
physico-chemical properties of these protein segments in the training set. We used 
multiple attributes including Shannon Entropy (SE), Relative Entropy (RE), Position 
Specific Scoring Matrix (PSSM), Predicted Secondary Structure (SS), Protein Disorder 
(DIS), Solvent Accessible Area, Overlapping Properties (OP), Sequence Complexity 
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(SC), and Averaged Cumulative Hydrophobicity (ACH). The details of calculation for 
these attributes are described in the following sections. 
2.2.1 Shannon Entropy (SE) 
SE score, a widely used sequence conservation measure, is calculated by 
weighted observed percentages (WOP) extracted from the results of PSI-BLAST (8) with 
Non-redundant protein sequence database. The WOP vector for a position in a given 
protein sequence shows the position-specific distribution of 20 amino acids. The SE score 
for the given position is defined as: 
 i
i
i ppSE log
20
1


 ,                                                            (1) 
where pi=ai/Σaj,  aj is the j-th value in the WOP vector for this given position. If a 
position has complete conservation, the SE score has the smallest value, 0. 
2.2.2 Relative Entropy (RE) 
RE measures the amino acid background distribution, and also requires the WOP 
matrix. The RE score of one type of amino acids is calculated as: 

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where pi =ai/Σaj,  aj is the j-th value in the WOP vector for this given position and p0 
is the protein BLOSUM62 background distribution. 
2.2.3 Position Specific Scoring Matrix (PSSM) 
PSSM is commonly used for the representation of motifs or patterns in biological 
sequences. To identify the pattern of neighbors besides key epitopic residues, we 
calculated the PSSM matrix using the BLASTP tool. PSSM can provide 20 bits for vector 
features. 
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2.2.4 Secondary Structure (SS) 
The most accurate way to obtain the information of secondary structures would be 
from the 3D structures of proteins. However, for a given protein sequence, the secondary 
structures can only be predicted. In this chapter, the SS attribute of each residue has three 
bits to show the possibility scores of three types of secondary structures (H: helix, E: β-
sheet, and C: coiled coil ) which is predicted by PSIPRED (9). 
2.2.5 Protein Disorder (PD) 
PD is important for protein function. Previous works suggest that protein disorder 
information is helpful to improve the discrimination between active sites and non-active 
sites (10). In our study, protein disorder areas are predicted by DISOPRED (11). The 
prediction result provides a score for each residue between 0 and 1, corresponding to 
more structured to more disordered status.  
2.2.6 Accessible Surface Area (ASA) 
All epitopic sites are on the surface of an antigen, and hence, large solvent 
accessibility is also an important feature of the catalytic residues. To improve the 
prediction accuracy, the solvent ASA information of each residue is included into the 
algorithm as well. The ASA attribute needs to be predicted from protein sequences. In 
our study, RVP-net is used to predict the relative solvent ASA for each residue in a given 
protein sequence (12). Each residue has a real value in (0, 1) for the ASA attribute.   
2.2.7 Averaged Cumulative Hydrophobicity (ACH) 
ACH has been demonstrated to be an important attribute for protein functional 
residues. The attribute is quantified by computing the average of the cumulative 
hydrophobicity indices over the segment sizes of 3, 5, 7, ... , 21, and 23AA. There are 
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ACH scores for 10 bits in the feature vector. The hydrophobicity index proposed by 
Sweet and Eisenberg is used in this chapter (13).  
2.2.8 K-nearest neighbor profiles (KNN)  
KNN usually is applied in the prediction of active sites, such as phosphorylation 
sites (4). A KNN score for one given sequence is the proportion of positive key epitopic 
residue in its k nearest neighbors in the training set where the distance between the two 
sequences is proportional to their sequence similarity; a pair of similar sequences has a 
short distance. The parameter k of KNN is set as 0.25%, 0.5%, …, and 5.and the KNN 
profile attribute has 20 bits.  
2.3 Training and Five-fold Cross Validation 
The training process is based on the Support Vector Machine tool, SVM
light 
(14). 
The kernel function used is the radial basis function, exp(-γ||a-b||2). To obtain the optimal 
training performance, we did a grid searching in the range of (c=2
-10~1
, g =10
-8~0
, and 
p=2
-5~0
) where c is the trade-off between training error and margin, g is the parameter γ in 
the radial basis function kernel, and p is the fraction of unlabeled examples to be 
classified into the positive class. For each segment length of the training dataset, the grid 
searching was independently executed and completed for different optimal parameter sets.  
 Five-fold cross-validation is executed for SVM training in the absence of an 
independent testing set. We first split the training dataset into five subgroups with the 
same size. Each group contains the same number of positive segments (epitopic residue 
inside) and negative segments (non-epitopic residue) as any other fold. During the 
procedure of making five groups, we make sure that a segment has more similarity with 
sequences in the same group than one from other group. The segments with more 
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sequence similarity are grouped in the same fold, which can significantly reduce the 
potential bias in the validation. During the five-fold cross-validation process, in turn the 
four folds are used to calculate the model and the last one is to evaluate the accuracy of 
the model calculated. 
The related statistical evaluation is listed below, 
Sen = 
TP
TP+FN
´100%
Pre = 
TP
TP+FP
´100%
F = 
2 ´ Pre ´ Sen
Pre+Sen
,
 
where TP, TN, FP, and FN stand for true positive, true negative, false positive, and false 
negative, respectively. All of calculations above are based on five-fold cross-validation 
procedure. We also generated the receiver operating characteristic (ROC) curve for 
statistical evaluation of SVMKER. In the ROC curve, false positive rate, i.e. FPR = FP / 
(FP + TN), is x-axis while sensitivity (Sen or true positive rate, as shown above), is y-
axis. Area under the curve (AUC) has been widely accepted as a performance index, with 
a higher AUC score representing a higher prediction performance. A java program 
available at http://pages.cs.wisc.edu/~richm/programs/AUC/ was used to calculate the 
AUC (15).  
 
3. Results 
The length of segments extending from epitopic residue will greatly impact the 
prediction. The shorter lengths, such as 3, 5, and 7AA, are difficult to generate a stable 
prediction performance. In current version of SVMKER, the eight attributes were applied, 
and they are SE (1 bit), RE (1 bit), PSSM (20 bits), SS (3 bits), ASA (1 bit), PD (2 bits), 
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ACH (10 bits), and KNN (20 bits). Using 3AA as example, the length of a feature vector 
for a given sequence segment is 7× (1+1+20+3+1+2+10+20) = 174. The small numbers 
of features for training might be the major reason to lower the prediction performance for 
3, 5, and 7AA. Under current conditions, 19AA is the most accommodative option, and 
hence, 19AA is used for the actual search of unknown proteins. 
Each segment lengths, i.e., 3AA, 5AA, 7AA, …, 19, 21, and 23 AA, showed the 
specific optimized parameter sets (Table 4.1). With the five-fold cross-validation, the 
statistical evaluation was obtained and it is also listed in Table 4.1. The predictions for 3, 
5, or 7AA length show very low performance. The reason may be the fact that short 
segments enclosing epitopic residue hardly provide enough information for classification. 
The best prediction is based on 19AA segment training dataset, and 17AA yields close 
prediction performance based on the F-measure. Furthermore, with longer segments as 
21AA and 23AA, the statistical evaluation showed worse prediction performance than 
19AA and 17AA (shown in Table 4.1). The influence of segment lengths on the 
prediction of key epitopic residue is similar to what we observed in sliding-window 
lengths on linear B-cell epitopes. For our previous tool, SVMTriP, the prediction on 
20AA is better than that on the shorter epitope lengths (16).  
 
Table 4.1 Statistical Evaluation of SVMKER with Different Lengths 
Segment c g p Sen Pre F 
3AA 0.25 0.01 0.0625 0.240 0.275 0.256 
5AA 0.25 0.001 0.125 0.232 0.270 0.250 
7AA 0.25 0.001 0.125 0.267 0.315 0.289 
9AA 0.125 0.0001 0.25 0.335 0.389 0.360 
11AA 0.25 0.001 0.125 0.387 0.445 0.413 
13AA 0.125 0.0001 0.125 0.468 0.434 0.450 
15AA 0.125 0.0001 0.25 0.522 0.483 0.502 
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17AA 0.125 0.001 0.25 0.572 0.535 0.553 
19AA 0.125 0.001 0.25 0.595 0.522 0.556 
21AA 0.125 0.0001 0.125 0.469 0.481 0.475 
23AA 0.125 0.0001 0.25 0.442 0.493 0.466 
 
 
We also compared SVMKER with our two conformational B-cell epitope 
prediction tools, EPCES (17) and EPSVR (18). The ROC curves of the three tools are 
shown in Figure 4.3 using a length of 19AA. EPCES shows the best prediction 
performance, EPSVR the second, and SVMKER the third. The AUC scores for EPCES, 
EPSVR and SVMKER are 0.632, 0.582, and 0.549, respectively. The fact that EPCES 
received a higher AUC score may be from different test dataset usage. It is in accordance 
with the facts that both EPCES and EPSVR are 3D structure-level tools while SVMKER 
is based only on protein sequences. All structural level information of a given antigen is 
known for EPCES and EPSVR. For EPCES and EPSVR, only surface residues are 
considered for prediction. However, SVMKER needs to predict epitopic residues from all 
amino acids of a given antigen.  
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Figure 4.3 ROC curves for EPCES, EPSVR, and SVMKER throughout five-fold 
cross-validation. The area under each ROC curve (AUC) is 0.632, 0.582, and 0.549, 
respectively. 
 
4. Discussions 
Compared with conformational B-cell epitope tools, SVMKER may possess more 
potential for the study of epitopes. For example, although EPCES and EPSVR have better 
performance than SVMKER, both require 3D structures of antigens, which greatly limit 
their applicability. After all, only a very small proportion of antigens have solved 3D 
structures. The determination of protein 3D structures using X-ray diffraction or nuclear 
magnetic resonance spectroscopy is time- and fund-consuming. SVMKER requires only 
a simple input, i.e., the amino acid sequence of protein candidate, and therefore, it is 
more practical for the immunologists. SVMKER has much wider applicability without 
the knowledge of 3D structure of protein candidates. Moreover, our comparison shows 
that the performance of SVMKER is close to that of EPSVR. Therefore, in despite of the 
room for accuracy improvement, as a sequence-level tool, SVMKER may be very useful 
in epitopic residue search as a preliminary filter for subsequent experimental design. 
SVMKER may not have yet reached the most optimal model. One of the reasons 
is the optimization of attributes. The eight attributes mentioned above are usually applied 
to predicting binding patterns and motifs. Note that some attributes are dependent to 
others. For example, PSSM is often a pre-condition considered in the prediction tool of 
protein secondary structure (9). PSSM and SS thus require to be treated as associated 
indices if they are both considered in SVMKER. Another issue is the normalization of 
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multiple attributes. In the current version of SVMKER, all the attributes have been 
normalized into the range of [0, 1]. To improve SVMKER, we will add more attributes 
into further consideration. The dependence and normalization of these attributes must be 
kept in mind. 
We calculated the weight scores of eight attributes in the 19AA optimized model. 
The weight scores are calculated by the formula w =∑ αi xi. Here α is dual representation 
of the decision boundary; and xi (i=0, 1, 2…n) is vector described in the SVM model. 
Both αi and xi are available in the model file. After normalizing weight scores of eight 
attributes, we illustrated their weight scores in the optimal model in Figure 4.4. Among 
these eight attributes, PSSM has the largest weight score (0.218) while PD is the least 
(0.049). That means that PD (the protein disorder feature) only weakly contributes to the 
determination of the SVMKER optimized model. The reason could be because of the low 
performance of the protein disorder prediction tool that we used. Considering the high 
weight scores of PSSM, SS, and KNN, the sequence similarity is still the major factor to 
determine the boundary between epitopic residue and non-epitopic residue. 
 
Figure 4.4 The Weight Scores of Eight attributes in 19AA optimal model. 
 
93 
 
 
 
Another way to improve SVMKER comes from the update of the training dataset. 
In the current version of SVMKER, we only applied the 3D structures of the antigen-
antibody complex deposited in the PDB database by June 2012. The 3D protein structures 
of antigen-antibody complex may precisely provide epitopic residues but the limited 
number of available 3D structures constraints the size of the training dataset. More 
resource should come from the IEDB database. By the end of 2013, there are more than 
50K B-cell epitopes reported in IEDB database. For most epitope entries, the 
corresponding binding sites or epitopic residues are recorded or suggested. Some of 
epitopic residues were determined by the determination of protein structure or point 
mutation experiments. However, most of epitopic residues in IEDB are still hypothetical 
from prediction tool and not suitable for training dataset. Obviously, our model cannot be 
simply based on these hypothetical epitopic residues since they are predicted and contains 
many false positives. It is necessary to carefully check and filter by excluding those 
hypothetical epitopic residues in IEDB before they are added to the training dataset. We 
believe that the SVMKER performance will be improved when more known epitopic 
residues are used to optimize the model. 
5. Conclusions 
In this chapter, we developed a new tool, SVMKER, to predict epitopic residues 
in antigens. The determination of epitopic residues greatly benefits the application of B-
cell epitope, such as vaccine design. It can act as the pre-condition for point mutation 
experiments on the validation of antigen. The current version of SVMKER reaches a 
precision of 59.5% and a sensitivity of 52.2% using five-fold cross-validation. In further 
evaluation, we compared SVMKER and EPCES and EPSVR. The AUC score of the 
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three tools is 0.549, 0.632, and 0.582, respectively. SVMKER shows a close prediction 
performance with EPSVR. Considering its significant advantage as a sequence-level tool, 
SVMKER meets much broader needs than EPCES and EPSVR, which are structure-level 
tools. We will keep improving SVMKER through further optimization of the attributes 
and the continuous enrichment of the training dataset using the IEDB database. All of 
optimal models, datasets, and online tool will be released for public usage in the future.  
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CHAPTER FIVE: SUMMARY AND FUTURE WORK 
1. Summary 
In this dissertation, we investigated several computational methods to identify the 
antigenic epitopes of protein candidate. First, a new linear B-cell epitope prediction tool 
SVMTriP was developed based on the combination of tri-peptide similarity and their 
propensity (1). Being compared with other linear B-cell epitope prediction tools, such as 
BCPred (2) and AAP (3), SVMTriP showed a better prediction performance with AUC 
score as 0.702 (BCPred: 0.667; AAP:0.667). Then, we developed a conformational B-cell 
epitope prediction tool called EPSVR and a meta server, EPmeta (4). EPSVR was 
developed based on six attributes with Super Vector Regression. EPmeta integrated 
multiple single servers, such as DiscoTope (5), PEPITO (6), SEPPA (7), EPITOPIA (8), 
EPCES (9), and EPSVR (4), to find a consensus result. The statistical evaluation based 
on an independent test dataset showed that EPSVR has the AUC score as 0.597 and 
EPmeta as 0.638. The third tool that we developed is SVMKER that can predict epitopic 
residues of an antigen sequence. To our knowledge, SVMKER currently is the first 
prediction tool of epitopic residues using protein sequence as input. These tools we 
developed provide more choices for immunologists to identify the antigenicity of protein 
candidate in a quick and cheap way. 
 
1.1 Linear Epitope Prediction 
Currently, Users can access SVMTriP by http://sysbio.unl.edu/SVMTriP. 
Generally, it takes 20-30 minutes to complete the prediction process for a protein 
sequence with a length of 200 AA. If any linear B-cell epitopes are found, they will be 
98 
 
 
 
listed with their scores and locations on the original protein sequence. Users can select 
different epitope lengths, from 10AA to 20AA, for their specific cases. In addition, the 
training dataset collected from IEDB (10) in SVMTriP is also shared online 
(http://sysbio.unl.edu/SVMTriP/Download). These dataset may benefit other B-cell 
prediction groups as references to develop new tools. 
Since May 12
th
 2012 when the online server was set up, SVMTriP has been 
visited more than 17,000 times, and more than 26,000 jobs were submitted for prediction. 
Moreover, we also helped other research groups to predict 12205 protein candidates by 
offline operation of SVMTriP. 
The application of SVMTriP helps immunologists to quickly narrow the range of 
protein candidates. A real case was reported from Dr. Yurij Innov‟s group, Department of 
Cancer Genetics, Roswell Park Cancer Institute, NY (private communications). In their 
investigation, two non-redundant linear epitopes on the human PAP protein were 
discovered by their experiment. One of these two linear epitopes was successfully 
predicted by SVMTriP. Other applications of SVMTriP were reported as well, such as 
meta-analysis of IgE-binding allergen epitopes (11) and prediction of IL4 Inducing 
Peptides (12). 
 
1.2 Conformational Epitope Prediction 
We also constructed the online servers for EPSVR (http://sysbio.unl.edu/EPSVR) 
and EPmeta (http://sysbio.unl.edu/EPmeta) in 2010. EPSVR requires an input of 3D 
structure of protein candidate when submitting a query. The average running time for 
EPSVR is 10-20 minutes. Same as EPSVR, EPmeta requires 3D structure of protein 
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when opening a new query. Usually, EPmeta requires much longer time that EPSVR 
because it needs to get the prediction results from all single servers, and then integrate 
into a consensus result. The statistics showed the average running time for a job is 1.5-2 
hours. 
The development of EPSVR and EPmeta give rise of new members for the very 
limited set of available conformational B-cell epitope prediction tools. EPSVR has been 
applied to the epitope prediction by many other groups. For example, a read case came 
from the identification of epitopes on D8 antigen (13). The prediction of D8 antigen 
using EPSVR generated 13 potential epitopic residues. After experimental validation by 
site-directed mutations, 6 of 13 variants indeed showed a significant drop in antibody-
antigen interaction (13).  
More antigen-antibody complex structures may increase the prediction 
performance for EPSVR. When we released EPSVR in 2010, only 98 antibody-antigen 
complex 3D structures were involved into the training of model. In the past four years, 
more and more antibody-antigen complex 3D structures were released. According to 
IEDB records, till June 2014, there were 591 antibody-antigen complex 3D structures 
reported in PDB database (14). Hence, it is possible to update the training dataset for 
EPSVR. 
 
1.3 Epitopic Residue Prediction 
Currently, the SVMKER approaches our preliminary requirement but still needs a 
further improvement. SVMKER reached a precision of 59.5% and a sensitivity of 52.2%. 
The five-fold cross-validation process showed the AUC value of SVMKER was 0.549, 
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which was lower than EPCES (0.632) and EPSVR (0.582). Considering the input of 
SVMKER was protein residue sequence while that of EPCES and EPSVR was protein 
3D structure, SVMKER is more valuable for real studies because most proteins do not 
have known 3D structures yet. 
The improvement of SVMKER is under our consideration. A possible way is to 
find more known epitopic residues and then increase the size of training dataset. Another 
strategy is to optimize the vector features of SVMKER model. By determining optimal 
weights of vector features, SVMKER is expected to show a higher AUC score.  
 
2. Future Work  
2.1 Importance of Food Allergen Prediction 
We will extend the epitope prediction tools that we developed to food allergen 
prediction. In chapter one, various types of B-cell antibodies, including IgE, which is 
mainly involved in allergy (15), were described. For atopic people, a specific allergen 
elicits T helper lymphocyte type 2 (Th2) responses (16), and leads to synthesis of 
allergen-specific IgE antibodies, which bind to mast cells and basophils. Further exposure 
to the antigen may stimulate the release of vasoactive mediators such as histamine and 
leukotrienes that cause the symptoms of allergy (17, 18). An IgE can recognize and bind 
to the allergen, which leads to a series of allergy-related symptoms. IgEs can bind to 
allergens and then stimulate the release of chemical materials, such as histamine and 
cytokinase, from the mast cells (19). Hence, allergen should contain at least one IgE 
binding site, i.e., epitope. 
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Among the variety of allergies troubling human beings, food allergy is one of the 
most prevalent diseases affecting almost all races in all geographic locations. Food 
allergy is a non-protective immune response triggered by food(s) specific to the affected 
individual, such as eggs, cow‟s milk, peanuts, certain tree nuts, soybeans, wheat, and 
other complex foods. Allergy is estimated to occur in over 20% of the population in 
industrialized countries, primarily as airway allergy, but with between 2-4% of adults and 
6-8% of children experiencing allergic symptoms following exposure to specific foods 
(20).  
The risk of food allergy is increasing synchronously due to the quick development 
and application of transgenesis in agriculture. Transgenesis can introduce one or more 
exogenous genes, so called transgenes, into a living target organism, such as agricultural 
crop or other interesting species. The transgenesis process means new proteins are 
expressed in the target organism which potentially increases the risk of food allergen. 
Our study on B-cell epitope prediction stimulates our interests on the prediction of 
food allergens. Considering the relationship between regular antigen dominant epitopes 
and allergens, we proposed to apply our developed tools, such as SVMTriP, EPSVR, and 
EPmeta to the prediction of allergens.  In the following sections, we will explain our 
primary research to assess the probability of an unknown protein as an allergen.   
2.2 Design of the Food Allergen Prediction Pipeline 
 The allergen prediction pipeline includes sequence similarity searching, protein 
structure modeling, sequence-level epitope predication, and 3D structure-level epitope 
prediction. Figure 5.1 shows the flowchart of the pipeline. 
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Figure 5.1: Allergen prediction pipeline using epitope tools 
  
The initial sequence similarity searching is done to broadly search for the allergen 
protein candidates including those with even low probabilities to be allergens. The 
allergen databases, such as AllergenOnline.org and AFDS, will be used in our pipeline 
for this step. For the result of sequence similarity search, the criteria include: 1) 
moderately long stretches of amino acid (80 amino acids) with a minimum of 35% 
identity and 2) very short stretches (6-8 amino acids) of 100% identity. The search result 
matching either of the two criteria will be treated as a potential allergen and therefore 
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qualified for the next check. In our preliminarily study, these initial hits from sequence 
similarity searching possibly contained rather many false positives, which must be 
eliminated by further refinement as discussed in the next sections. 
 If protein candidate has no available 3D structure, we will apply linear B-cell 
epitope prediction tool such as SVMTriP and SVMKER. By SVMTriP, sliding-window 
search along the protein sequence is executed to determine the epitopic probability. With 
the pre-defined cutoff (the default cutoff is 0.2), once the epitopes are picked up, these 
potential antibody-binding sites, usually with 8-20 amino acids, will have another round 
of similarity search against allergen databases, such as AllergenOnline.org and AFDS. If 
the high similarity hits (>80%) find in allergen databases match the epitopes from 
SVMTriP, the protein candidate is thought of one allergen with a high confidence. 
 If the 3D structure of protein candidate is available, conformational epitope 
prediction tools such as EPSVR, EPCES, and EPmeta can be used. If the protein structure 
is not available, we will conduct the structural modeling  to predict the protein structure 
with SPARKS-X, a tool to predict 3D protein structures (28, 30). After the 3D structure is 
predicted, conformational B-cell epitope tools will continue the rest of prediction 
processing. 
 
2.3 Summary 
Our developed B-cell epitope prediction tools are the good supplement for the 
prediction of allergens. Considering the very limited resource of known allergens and 
even more limited knowledge regarding IgE-binding sites on these allergens, it is quite 
difficult to apply any machine learning technologies to the classification and 
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identification of IgE binding site on proteins. Currently the most common strategy still 
relies heavily on the traditional sequence similarity search using FASTA and BLASTP 
tools. However, the results from FASTA and BLASTP contain an unsatisfactory level of 
false positive rates. In the pipeline we designed, we apply the similarity search method as 
well as epitope prediction methods, both linear and conformational, to predict the 
potential epitopic sites on a protein candidate. The discovery of antibody epitopes will 
increase the confidence level for the allergen prediction. The candidates with low scores 
that do not pass the checking point of epitopic sites are eliminated to decrease the false 
positive rate from the sequence similarity search.  
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